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ABSTRACT 
At this point, nothing is known about how peptidergic afferents/ efferents of the 
medial preoptic-anterior hypothalamic continuum (MPOA-AH) participate in the 
neural control of male rat sexual behavior. In this dissertation an attempt was 
made to elucidate the roles of substance P (SP) and cholecystokinin (CCK) (two 
peptides found within the MPOA-AH) in male rep~oductive behavior. In 
Experiments 1 through 4, a variety of parameters of male copulatory behavior 
were recorded subsequent to intracerebral injections of SP into the MPOA-AH or 
the dorsal caudate/putamen (CP). Data from these experiments revealed that 
bilateral cannulae implanted in the .MPOA-AH produced a partial lesion which 
disrupted the pattern of male copulatory behavior which was dependent on a 
post-operative test interval. Following the establishment of a new testing 
interval, a second series of experiments were conducted using a similar approach 
to that of experiments 1-4. In Experiments 8 and 9, an undiluted SP antiserum 
(0.3 ul or 2 ul) was injected bilaterally into the MPOA-AH. In Experiment 11, 
three different doses of CCK-8 (sulphated) were bilaterally injected into the 
MPOA-AH and the effects on male copulatory behavior following these doses were 
examined. Bilateral injections of 10, 100, and 200 ng/cannula, of acidified SP 
into the MPOA-AH significantly reduced the latency to initiate copulation, while 
the two lower doses also reduced ejaculation latencies. In addition, all three doses 
of SP significantly reduced the number of mounts while the 100 ng dose also 
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decreased the number of intromissions prior to ejaculation. In contrast to 
gonadally intact males, 1-iPOA-AH injections of 10 ng of SP in castrated 
testosterone-deprived animals had no appreciable effect on copulatory behavior. 
Bilateral injections of 2 ul of a SP antiserum significantly increased mount, 
intromission, and ejaculations latencies and caused a significant increase in the 
inter-copulatory interval. In contrast to the :MPOA-AH, bilateral injections of SP 
into the CP had no appreciable effect on male copulatory behavior. Injections of 
SP into the LV significantly reduced the number of intromissions to ejaculation, 
while at the same time lengthened both mount latencies and the inter-copulatory 
interval. CCK-8 injections into the :MPOA-AH had no significant effect on any of 
the parameters of copulatory behavior, although there was a non-significant trend 
for reduced latencies following the larger doses of CCK-8 compared to saline 
injected con trois. This is the first study to demonstrate that SP, a peptide 
previously implicated in female sexual behavior, and with a sexually differentiated 
distribution in the CNS, plays an important role in the neural regulation of male 
sexual behavior. 
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GENERAL INTRODUCTION 
In the search for a neurophysiological understanding of rat sexual behavior , 
experimental interest has focused on two inter-connected physiological systems: 
the endocrine system and the central nervous system (CNS). Each system has 
been shown to be of crucial importance for both the initiation and maintenance of 
female and male sexual behavior. For example, in the male the testes produce 
male hormones (androgens) which are secreted into the bloodstream, where they 
interact with different tissues within the body as well as within the CNS, to 
ensure the adequate functioning of the male copulatory sequence. Similarly, 
within the ovary secretion of ovarian hormones (estrogen and progesterone) 
ensures maximum sexual efficiency in the female. Removal of the testes or 
ovanes results in abolition of the sexual behavior in males and females 
respectively. 
As a result of unprecedented advancements in neuroanatomical techniques 
employed in brain-behavior research in the past two decades, a considerable 
amount of information is now available concerning the neural control of male and 
female sexual behavior. This introduction will deal with the neural basis of male 
sexual behavior. Primary emphasis will be directed toward the role of the medial 
preoptic-anterior hypothalamic continuum (.MPOA-AH) in male sexual behavior. 
In addition, the role of neurotransmitters and neuropeptides in the regulation of 
male sexual behavior in both animals and humans will be reviewed. Prior to this, 
a description of the copulatory pattern in the male rat will be given. 
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Below is a schematic representation of the basic features of male copulatory 
behavior. 
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Figure 1 
f Mount J tnuonuss.on 
Masculine mating behavior in the rat. 
Taken from Larsson (1979). 
As can be seen, three behaviors, along with their respective latencies, are 
recorded: 1) mount, this consists of shallow, repetitive pelvic thrusting by the 
male without penile insertion into the vagina; 2) intromission, a -mount with deep 
pelvic thrusting which results in penile insertion into the vagina, whereupon the 
male dismounts with a quick backward springing movement; 3) ejaculation, here 
the mount is terminated by a deep pelvic thrust which is maintained for several 
seconds with the forepaws extended. As can be seen from the figure, each 
copulatory pattern consists of repeated mounts and intromissions which 
eventually culminate in ejaculation. Generally, the initial ejaculation is preceded 
by 8 to 15 intromissions, whereas second and subsequent ejaculations are preceded 
by progressively fewer intromissions (3- 7). After the first ejaculation, the male 
goes through a period of sexual quiescence (about 4 to 8 minutes). This interval 
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has been termed the • refractory period • or • postejaculatory interval • (PEl) . 
Beach and Holz-Tucker (1949) originally divided the PEl into two components: 
an • absolute • refractory period during which the male is unresponsive to 
exogenous stimulation, and a shorter • relative • refractory period, where 
mounting will take place if the male is given sufficient stimulation (e.g. pinching 
of the tail). With each successive ejaculation, the PEls increase. Given sufficient 
time, however, a male rat may achieve 8 to 12 ejaculations before becoming 
sexually exhausted. 
An interesting component of the male copulatory pattern is its temporal 
organization. For instance, each intromission lasts about 1/2 second, and there is 
generally an interval of 30 to 60 seconds between intromissions (inter-copulatory 
interval, ICI). If the ICI is experimentally manipulated, dramatic effects on the 
male copulatory sequence result. Hard and Larsson ( 1970) reported that by-
prolonging the ICI (enforced-interval), male rats ejaculated after fewer 
intromissions. However, if this interval is prolonged for too long a period, males 
may not ejaculate despite repeated mounts and intromissions (Larsson, 1970). 
\Vhat these studies suggest is that the CNS stores the stimulation received during 
each successive intromission, and that ejaculation is dependent on the culmination 
of this excitation. Therefore, in the • enforced-interval• paradigm, as the I Cis are 
progressively ~:.:tci·eased beyond a certain point, each subsequent intromission is 
building on less and less excitation. 
Besides the above temporal organization of the male rat mating sequence, 
several circumscribed behavioral patterns characterize the male copulatory 
sequence. For example, upon presentation of a receptive female, a sexually 
vigorous male will immediately approach and sniff the female's anogenital region. 
He will also continually pursue the female, sometimes climbing on her back, or 
crawling over the body and head (Larsson, 1979). 
This section has highlighted some of the major components of the male 
copulatory pattern. In the next section, evidence in support of MPOA-AH in the 
regulation of male sexual behavior will be briefly reviewed. 
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NEURAL CONTROL OF MALE COPULATORY BEHAVIOR 
Medial Preoptic Area 
(MPOA-AH). 
Lesions: 
Anterior Hypothalamic Continuum 
.Numerous experimental studies clearly indicate the importance of the MPOA-
AH in neural regulation of male copulatory behavior. Large lesions of the MPOA-
AH result in the total cessation of male copulation (see figure next page). This 
has been demonstrated in a variety of species, including the rat (Arendash and-
Gorski, 1983; Caggiula, Antelman and Zigmond, 1973; Ginton and Merari, 1976; 
Heimer and Larsson, 1966-67; Singer, 1968; Twiggs, Popolow, and Gerall, 1978), 
cat (Hart, Haugen and Peterson, 1973), dog (Hart, 1974; Hart and Ladewig, 1979), 
rhesus monkey (Slimp, Hart and Goy, 1978), and also in several nonmammalian 
species such as frogs (Schmidt, 1968) and lizards (Wheeler and Crews, 1978). 
In a now classic study by Heimer and Larsson ( 1966-67), the critical areas for 
male sexual behavior within the MPOA-AH were delineated by making small 
lesions throughout the continuum. Although lesions within the medial preoptic 
area (MPOA) suppressed male sexual behavior, Heimer and Larsson concluded 
that there were no specific locations within the MPOA-AH that were essential for 
male sexual behavior in the rat. 
Recently, however, a number of investigators have revealed the importance of 
discrete portions of the MPOA-AH. Van de Poll and van Dis ( 1977) revealed that 
bilateral destruction of the entire rostral MPOA-AH did not affect male sexual 
behavior in the rat, whereas destruction of the caudal part of the ~1POA-AH 
completely abolished its expression. Arendash and Gorski ( 1983) demonstrated 
5 
I , 
Figure 2 Schematic representation showing extent of 
MPOA-AII lesions that disrupt male sexual 
behavior in male rats. Numbers identify the 
figures in the Konig and Klippel atlas. Taken 
from Hennessey, Wallen, and Edwards (1986). 
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that discrete lesions of the dorsal "MPOA-AH produced the most dramatic effects 
on male sexual behavior, while discrete lesions of the ventral "MPOA-AH were not 
as effective. As a result, they concluded that the dorsal "MPOA-AH may be 
differentially more important than other !v!POA-AH regions in the neural 
regulation of male sexual behavior in the rat. 
With respect to !v!POA-AH lesions, the effects seem to be permanent in that 
functional recovery of male sexual behavior is not detected for as long as 8 
months post lesion (Ginton and Merari, 1976). 
In the above studies, non-selective lesioning techniques were employed to destroy 
MPOA-AH tissue. Therefore, it is not known whether the deficits observed were 
the result of damage to "MPOA-AH neuronal cell bodies or to axons passing 
through the !v!POA-AH (axons of passage). Recently, Hansen, Kohler, Goldstein-
and Steinbusch (1982) have demonstrated that lesions of the "MPOA-AH made 
with a neurotoxin, ibotenic acid (ibotenic acid produces relatively selective 
destruction of cell bodies while leaving axons passing through the area intact), 
were as effective as electrolytic lesions in eliminating male sexual behavior in rats. 
These data corroborated t- .1rlier results with non-selective electrolytic lesions, and 
further suggest the critic.al importance of !v!POA-AH cell bodies in the neural 
regulation of male sexual be~avior in the rat. 
Electrical Stimulation: 
The importance of the !v!POA-AH in the neural control of male sexual behavior 
is further strengthened by results obtained with electrical stimulation techniques 
(Hillarp, Olivercrona and Silfverskiold, 1954; Malsbury, 1971; VanDis and 
Larsson, 1970). For example, Malsbury (Hl71) reported that electrical stimulation 
in the !v!POA-AH reduced the number of mounts and intromissions preceding 
ejaculation. In addition, in two animals, a dramatic decrease in the 
postejaculatory interval (PEl), along with shortened approach and mount 
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latencies were observed. In another study by Van Dis and Larsson (1970) they 
reported an abnormally high incidence of ejaculations following electrical 
stimulation of the :MPOA-AH (one of the rats ejaculated 17 times in only a 30 
minute interval). They also recorded drastically shortened PEls. 
Summary 
The critical importance of the :MPOA-AH in the neural regulation of male 
sexual behavior has been clearly demonstrated in studies using a variety of 
experirr_ental approaches. As the review above indicates, bilateral lesions of the 
~fPOA-AH greatly impair or completely abolish male sexual behavior in the rat, 
while electrical stimulation greatly enhances the behavior. Indeed, as Larsson 
(1979) states: • the :MPOA-AH may be viewed as the origin of the final common_ 
pathway for [male] sexual behavior •. 
In the following section, evidence for the role of neurotransmitters and 
neur :,)eptides in the regulation of male sexual behaYior in both animals and 
ht. :.aans will be reviewed. 
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MONOAMINES AND MALE SEXUAL BEHAVIOR 
Several lines of experimental evidence indicate that brain monoammes play a 
significant role in the regulation of male sexual behavior in rat (Ahlenius, Larsson , 
and Svensson, 1980; Baum and Starr, 1980; Clark, Smith, Stefanick, Arneric , 
Long, and Davidson, 1982; Hull, Bitran, Pehek, Warner, Band, and Holmes, 1986), 
cat (Hoyland, Shillito, Vogt, and Tje, 1970), rabbit (Perez-Cruet, Taligamonte, 
and Gessa, 1971), as well as in humans (Gawin, 1978; Green, 1961; Mitchell and 
Popkin, 1983; Redmond, Kosten, and Reiser, 1983). In this section, evidence m 
support of the above will be reviewed. 
Dopaminergic Modulation of Male Sexual Behavior 
Animal Studies 
In the rat, considerable evidence indicates that dopamine (DA) serves a 
facilitatory role in male sexual behavior. A variety of treatments which decrease 
DA activity have been reported to impair male copulatory behavior (Baum and 
Starr, 1980; Malmnas, 1973; Mcintosh and Barfield, 1984b), while treatment with 
drugs which enhance DA activity has produced facilitatory effects (Ahlenius and 
Larsson, 1984; Hull et al. 1986; Paglietti, Pellegrini-Quarantotti, Meru,and Gessa, 
1978). 
One of the earlier studies that investigated the role of dopaminergic mechanisms 
in male rat sexual behavior was done by Butcher, Butcher and Larsson ( 1969). 
Following intraperitoneal administration of 3,4,- dihydroxyphenylalanine (L-
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DOPA) in sexually experienced males~ they observed a significant reduction in 
intromission frequency (number of intromissions preceding ejaculation), as well as 
in ejaculation latencies, compared to a saline-infected control group. 
In a second study, Paglietti et al.(1978) reported similar results. Following 
peripheral administration of apomorphine (APO, a DA agonist) or L-DOPA to 
sexually vigorous ::;onadally intact males, they observed a significant reduction in 
both intromission and ejaculation latencies compared to baseline (no treatment) 
scores. In addition, intraperitoneal administration of L-DOP A significantly 
reduced the number of intromissions preceding ejaculation, an effect not seen 
following APO treatment. Pre-treatment with the DA receptor blocker pimozide 
completely abolished the effects of 1-DOP A and APO. 
Subsequent investigations using sexually experienced or inexperienced male rats,-
have reported a facilitation of male copulatory behavior following administration 
of DA agonists. Indeed, it is generally accepted that DA receptor activation 
amplifies male copulatory behavior. Agreement as to the site of the DA receptor 
mediated effect, however, is still to be reached. Two important theories regarding 
the site of the effect have been proposed. One is based on the assumption that 
dopamine is an inhibitory transmitter, and suppression of its activity (via 
autoreceptor stimulation) is how DA agonists facilitate male copulatory behavior 
(Gower, Berendson, Princen, and Broekkamp, 1984). When activated, these 
presynaptic autoreceptors v1a a negative feedback mechanism decrease 
presynaptic release of DA, consequently reducing endogenous DA at the 
postsynaptic receptor. The other is in line with the previously mentioned studies, 
and argues that postsynaptic DA receptor activation is the mediating factor. 
Recently, Foreman and Hall (1987) have published a series of experiments which 
have attempted to clarify the above issue. Their data, along with the previously 
mentioned studies, strongly support a role for the involvement of increased 
postsynaptic DA receptor mediated responses as the basis for the facilitation of 
male copulatory behavior. In the study by Foreman and Hall (1987), activation of 
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presynaptic DA autoreceptors, or postsynaptic receptors , following subcutaneous 
administration of different doses of a selective D2 receptor agonist (L Y163502), 
produced dose-related effects on male copulatory behavior. Low doses of 
L Y163502 (0.025-10 ng/kg) significantly reduced the percentage of animals 
ejaculating during the 30 minute mating test, while intermediate doses produced 
the opposite effects. Reductions in mount and intromission frequencies , as well as 
ejaculation latencies , were observed following intermediate doses (25 ng-25 
ug/kg). The effects of L Y163502 were completely abolished by pre-treatment with 
the centrally acting dopamine receptor blocker sulpiride, but were not affected by 
a peripherally acting dopamine antagonist, domperidone. Based on these results, 
they conclude that lew doses of L Y163502 impair male copulatory behavior by 
stimulating central presynaptic DA autoreceptors, whereas the moderate doses 
enhance copulatory behavior via increased central postsynaptic DA receptor 
activity. 
Clearly, the use of highly selective receptor agonists will provide a useful tool for 
determining the functional significance of pre and postsynaptic dopamine 
receptors in the regulation of male sexual behavior. Presently, however, much 
further systematic research is required before any firm conclusions can be drawn. 
A number of studies hav~ revealed that the dopaminergic enhancement of male 
rat copulatory behavior may be independent of gonadal as well as adrenal 
hormone influence (Meyerson, Malmnas, and Everitt, 1985; Malmnas, 1977; 
Ahlenius, 1981). For example, Malmnas (1977) administered APO to castrated 
rats eight weeks following castration and observed a significant increase in the 
number of animals that displayed mounting, intromission, and ejaculation 
compared to a saline-injected control group. In addition, reinstatement of the full 
copulatory pattern in castrated rats was completely abolished by pre-treatment 
with pimozide. In that same study, Malmnas tested the possible contribution of 
adrenal hormones in male copulatory behavior following peripheral injections of 
APO in a group of castrated/ adrenalectomized animals. Here too APO was 
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effective in reinstating copulatory behavior , although the increase in the number 
of animals ejaculating did not reach statistical significance. 
In the preceding studies, the effects on rat copulatory behavior subsequent to 
changes of dopaminergic activity were observed following systemic administration 
of drugs. One major problem with systemically-administered drugs is that it is not 
clear where the central site of action is, since they affect numerous neural 
systems. Accordingly, although the MPOA-AH has been demonstrated to play a 
significant role in male rat sexual behavior, it is not clear from the 
aforementioned studies if MPOA-AH dopaminergic synapses mediate the effects of 
the sysiemica!ly administered drugs. Recently, Hull et al. ( 1986) have 
demonstr 1-.:.ed ·-:;he importance of MPOA-AH dopaminergic regulation of 
copulator:,r behavior in the male rat. Compared to a saline-injected control group, 
unilateral injections of APO into the MPOA-AH increased the percentage of 
mounts with intromission (h"t rate), and the number of ejaculations, while they 
decreased the latency to ejaculate, and the postejaculatory interval during a 30 
minute mating test. Injections of APO into the caudate/putamen or the lateral 
septum had no appreciable effect on copulatory behavior. Interestingly, when 
injected ~nto the lateral ventricle, APO produced differential effects on some of 
the par~meters of male copulatory behavior. For example, unilateral injections of 
APO (0.5 ug) significantly increased hit rate, while a lower dose (0.2 ug), actually 
impaired copulatory behavior, revealed by decreased ejaculatory frequency and an 
increased inter-intromission interval (i.e. decreased copulatory vigor). The authors 
suggested that the low dose of APO injected into lateral ventricles was acting on 
presynaptic DA autoreceptors. They speculated that the subsequent decreased DA 
activity at post synaptic receptors in the MPOA-AH results in an impairment of 
copulatory behavior in the rat. Conversely, they suggest that the higher dose of 
APO was stimulating postsynaptic receptors, which resulted in a facilitation of 
copulatory behavior. Although an intriguing interpretation, further research is 
needed before the functional significance of DA autoreceptors for male rat sexual 
behavior is elucidated. 
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Human Studies 
The significance of dopaminergic mechanisms in human sexuality has been 
demonstrated by studies which reveal therapeutic or detrimental effects on sexual 
behavior following administration of drugs that enhance or decrease dopaminergic 
activity respectively. For example, Bowers, van Woert, and Davis (1971) reported 
that of nineteen patients that were receiving L-DOP A treatment for Parkinson's 
disease, seven (37%) reported increased sexual activity during treatment. In fact , 
hypersexuality has been a reported clinical complication of dopaminergic therapy 
in Parkinson's disease (Vogel and Schiffter, 1983). Conversely, drugs that decrease 
dopaminergic activity have been reported to disrupt sexual behavior (Ananth,-
1982; Buffum, 1982; Mitchell and Popkin, 1982; Singh, 1963). Indeed, the use of 
chlorpromazine has been associated with dose-related sexual dysfunctions in men. 
Mitchell and Popkin ( 1982) report that in male schizophrenics, chlorpromazine at 
a dose of 1,200 mgfday resulted in failure to ejaculate, decreased erectile ability, 
as well as decreased libido. When the dose was lowered to 400 mg/ day, libido and 
erectile ability returned, although ejaculation did not. 
In a systematic investigation of dopaminergic mechanisms m male sexual 
behavior Ghadirian, Chouinard, and Annable (1982) found that, following 
treatment with a dopamine receptor blocker, fluphenazine, in 55 schizophrenics, 
38 percent reported having difficulty in achieving erection, 42 percent in 
maintaining an erection, and 58 percent in achieving orgasm. Similarly, in a 
clinical case history Ananth ( 1982) reported that impotence was induced in a male 
schizophrenic following treatment with pimozide. That pimozide was directly 
responsible for the sexual dysfunction and not secondary to the disorder itself, was 
suggested by the alleviation of the impotence following its discontinuation. 
Moreover, on two separate occasiOns following re-instatement of pimozide 
treatment, his impotence returned. 
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· In summary, it seems clear from the above that dopamine neurons play an 
important role in the regulation of both animal and human sexual behavior. Drugs 
that decrease or enhance DA activity impair or facilitate sexual behavior 
respectively. In addition, in the only study that has investigated the role of DA by 
using direct injections of APO into the brain , Hull et al. ( 1984) report that only 
MPOA-AH, and not caudate/putamen or lateral septum injections of APO, 
dramatically facilitated copulatory behavior in male rats. As a result, they suggest 
that the MPOA-AH is an important structure in the dopaminergic regulation of 
male sexual behavior. 
The Role of 5-hydroxytryptamine {5-HT) in Male 
Sexual Behavior 
In contrast to DA, evidence suggests that serotonin (5-HT) serves l).n inhibitory 
role in male sexual behavior in animals as well as humans. A variety of 
treatments which increase 5-HT activity disrupt male sexual behavior (Ahlenius, 
Larsson, and Svensson, 1980; Hansen, Svensson, Hokfelt, and Everitt, 1983; 
Malmnas and Meyerson, 1971.; Quirk and Einarson, 1982; Svensson and Hansen, 
1984; Wilson, Pearson, Hun·cer, Tuothy, and Payne, 1986), while those which 
decrease 5-HT activity appear to facilitate sexual behavior (Ahlenius, Heimann, 
and Larsson, 1979; Dewsb·,uy, 1972; Larsson, Fuxe, Everitt, Holmgren, and 
Sodersen, 1978; Mcintosh and Barfield, 1984a; Sodersten, Larsson, Ahlenius, and 
Engel, 1976). 
Animal Studies 
Ahlenius et al. ( 1980) report that following peripheral administration of a 
selective 5-HT reuptake blocker, zimelidine, along with a sub-threshold dose of 5-
hydroxytryptophan (5-HT precursor) to sexually experienced male rats, they 
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observed a prolongation of the ejaculation latency and the postejaculatory 
interval. This effect was completely abolished by pre-treatment with a 5-HT 
receptor blocker. Further support for an inhibitory role of 5-HT on male sexual 
behavior comes from studies that have utilized the 5-HT synthesis inhibitor p-
chlorophenylalanine (PCP A). In male rats, PCP A has been shown to increase the 
• intensity • of copulation (increase the number of mounts and intromissions per 
minute) and to decrease ejaculation latencies (Meyerson, Malmnas, and Everitt, 
1985). Furthermore, PCPA treatment has been shown to reinstate the full 
copulatory pattern in castrated male rats given subthreshold doses of testosterone 
(Malmnas and Meyerson, 1971). For example, in a study by Sodersten, Larsson, 
Ahlenius, and Engel ( 1976), castrated rats were given daily subthreshold doses of 
testosterone (T) (20 mg/kg) along with PCPA. Following combined treatment 
with T and PCPA~ 80 %of the males ejaculated compared to none in the T alone 
-
group. Moreover, pre-treatment with 5-HT completely abolished the facilitatory 
effect of PCP A. 
Despite the evidence supporting an inhibitory role of 5-HT m male sexual 
behavior, there are some conflicting reports in the literature (Gorzalka and 
Whalen, 1975; Mendelson and Gorzalka, 1985). In some studies pharmacological 
treatment which enhanced serotonergic activity was ineffective (Hansen, Svensson, 
Hokfelt, and Everitt, 1983), or produced contradictory effects on male copulatory 
behavior (Svensson and Hansen, H}84). 
A number of studies have attempted to explain some of these discrepant results. 
For instance, Larsson (1979), in his review on monoaminergic control of male 
sexual behavior, describes an experiment where marked strain differences were 
found in the activating effects of PCP A on the male copulatory pattern. Wistar 
and Sprague-Dawley rats were castrated at 70 days of age and then treated with 
PCP A 3 weeks later. On subsequent behavior tests, none of the Sprague-Dawley 
rats displayed copulatory behavior, whereas 85 % of the Wistar rats ejaculated. 
Therefore, the inhibitory effects on male copulatory behavior produced by 5-HT 
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may depend on the strain of rat used. In other words, PCP A may enhance sexual 
behavior in castrated rats of some strains while being completely ineffective in 
others. 
Another interpretation has been recently postulated by Mendelson and Gorzalka 
(1985). In that study, peripheral administration of pirenperone and ketanserin 
(selective 5-HT 2 receptor antagonists) inhibited sexual behavior in male rats 
compared to the saline- injected controls. This was revealed by dramatic increases 
in mount, intromission, and ejaculation latencies. They also reported that 
intraperitoneal injection of a 5-HT 2 receptor agonist ( quipazine) in sexually 
experienced male rats also inhibited sexual behavior. Indeed, the inhibitory effects 
observed, whether following administration of the antagonist or the agonist, were 
virtually indistinguishable. Interestingly, while both quipazine and pirenperone 
when injected alone produced an impairment of copulatory behavior, when 
administered simultaneously, the inhibitory effects of both drugs were markedly 
attenuated. They explain the apparent paradox in their results by postulating a 
dual role (facilitatory and inhibitory) for 5-HT in male sexual behavior. In fact, 
based on these results, they suggest that experiments should focus on the changes 
produced m male copulatory behavior following drugs with specific 
pharmacological effects on 5-HT receptor subtypes. They state that past research 
investigating the role of 5-HT in male sexual behavior is based on drugs with non-
specific effects or.. 5-HT r2ceptors, wb. .ich could partly explain the conflicting 
reports in the liter:1ture regarding 5-HT's role in male copulatory behavior. 
Recently, Mendelson and Gorzalka (1986) have further explored the possibility 
of a differential role for 5-HT in male sexual behavior. Based on pharmacological 
studies which have revealed that the 5-HT 1 class of receptors consists of a 
further subtype, A and B, and on the recent evidence which has demonstrated 
differential physiological function of serotonin receptor subtypes, they investigated 
the role of 5-HT 1 (A) and 5-HT 1 (B) receptors in male copulatory behavior. 
They report that peripheral administration of 8-0H DPAT, a 5-HT 1 (A) receptor 
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agonist, significantly reduced ejaculation latencies and the number of 
intromissions prior to ejaculation. They conclude that activation of both 5-HT 1 
(A) or 5-HT 2 receptors facilitate the expression of male copulatory behavior in 
gonadally intact males, and suggest that the inhibitory effects that have been 
reported in the literature following increased serotonin activity are probably 
mediated by a population of serotonin receptors other than those of the 5-HT 1 
(A) and 5-HT 2 subtype. Why they conclude that activation of both 5-HT 1 (A) 
and 5-HT 2 receptors facilitate male sexual behavior, when in their previous study 
a specific 5-HT 2 agonist impaired male copulatory behavior, is not clear. 
Although still an interesting interpretation, in view of a study by Ahlenius and 
Larsson (1g84), the role of 5-HT receptor subtypes in the regulation of male sexual 
behavior remains unclear. For example, they too reported that, following 
intraperitoneal administration of 8-0H DPAT in gonadally intact sexualli 
experienced male rats, a significant decrease m intromission frequency and 
ejaculation latencies was observed compared to control (saline) injections. 
However, prior treatment with specific 5-HT 1 and 5-HT 2 receptor blockers did 
not attenuate the 8-0H DPAT-induced facilitation of male copulation in that 
study. Based on these results, Ahlenius and Larsson (1984) concluded that the 8-
0H DPAT-induced facilitation of copulatory behavior observed in their study was 
not mediated via 5-HT receptors. Indeed, they speculated that the 8-0H DPAT-
induced facilitation of male copulatory behavior is probably mediated via 
catecholamine receptors. 
Human Studies 
PCP A, used in the treatment of migraine headaches, has been reported to be 
associated with increased levels of sexual excitation in migraine patients (Sicuteri, 
Del Bene, and Anselmi, 1g75). In that study, male migraine patients were divided 
into two groups. One group received an oral dose of PCP A plus an intramuscular 
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injection of a placebo (control group) , the second group received an oral dose of 
PCP A plus an intramuscular injection of testosterone. PCP A plus testosterone 
treatment significantly increased the number of daily erections compared to the 
controls. Testosterone alone did not appear to be responsible for the effect as a 
previous study by Sicuteri ( 197 4) showed that testosterone treatment of migraine 
sufferers was no better than placebo. This has rather interesting implications. For 
example·, migraine sufferers have been reported to have decreased libido. 
Moreover, migraines have b2en associated with increased plasma 5-HT levels. 
Therefore, it is not inconce1vable that in migraine sufferers, chronically high 5-HT 
levels reduce sexual desire, and that treatment with PCP A by lowering 5-HT 
levels increases sexual interest by enhancing performance. One problem with this 
assumption is that frequently it is exceedingly difficult to ascertain whether sexual 
dysfunctions that occur during an illness are indeed precipitated by changes in 
neurochemical systems (i.e. 5-HT activity) or represent psychological disturbances 
that are secondary to the illness. Nonetheless, PCP A treatment in humans 
produces effects on sexual behavior that are consistent with the animal literature, 
and as a result, do support a role for 5-HT in the regulation of male sexual 
behavior. 
Further support for 5-HT iL male sexual behavior has come from reports of 
sexual dysfunctions following the use of anti-depressant drugs, some of which are 
relatively s:)ecific 5-HT reuptake blockers (Mitchell and Popkin, 1983). For 
example, in a recent paper by Jones ( 1984) he describes a case history of a middle-
aged depressed male who experienced ejaculatory inhibition after being treated 
with Trazodone (a selective inhibitor of 5-HT reuptake). During treatment, the 
patient denied any problems with his ability to maintain an erection, or pain 
during sexual intercourse (a frequently reported side effect), but he did complain 
of an inability to ejaculate on numerous occasions. Three days after the 
discontinuation of Trazodone, he reported having satisfactory intercourse and had 
absolutely no difficulty ejaculating. 
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Summary 
In view of the above studies, it can be concluded that 5-HT has an important 
function in masculine sexual behavior in both the rat and human. The majority of 
studies are suggestive of an inhibitory function of 5-HT. For example, most of the 
components of male copulatory behavior are enhanced following decreases in 5-
HT activity , whereas inhibitory effects are obtained by increasing 5-HT activity. 
Recently, however, a number of reports challenge the theory of an inhibitory role 
for 5-HT in male sexual behavior. Based on observations following treatment with 
drugs with specific actions on 5-HT receptor subtypes, Mendelson and Gorzalka 
have revealed differential involvement of 5-HT receptors in the expression of male 
sexual behavior, and as a result suggest a dual role (facilitatory and inhibitory) for 
5-HT in male sexual behavior. As illustrated in the Ahlenius and Larsson ( 1984)_ 
study, however, at present the identity of the neurons which mediate the effect of 
8-0H DPAT on male copulatory behavior is unclear. 
The Role of Norepinephrine (NE) in Male Sexual 
Behavior 
It is only within the .last several years that more attention is being focussed on 
the role of norepinephrine (NE) in male sexual behavior. Although there 1s an 
abundance of studies in the literature on the disruptive effects of anti-
hypertensive drugs (almost all of which are anti-adrenergic) on human sexual 
behavior, ironically, there has been little research investigating NE in rat 
copulatory behavior. There are, however, numerous studies that clearly suggest a 
role for NE in the regulation of male sexual behavior in both humans and animals 
(Ahlenius, Heimann, and Larsson, 1979; Clark, Smith, and Davidson , 1984; 1985; 
Fernandez-Guasti, Hansen, Archer, and Johnsson, 1986; Hoehn-Saric, Merchant, 
Keyser, and Smith, 1981; Johnson and Diamond, 1969; Laver, 1974; l\·fclntosh and 
Barfield, 1984c; Redmond, Kosten, and Reiser, 1983; Stefanick, Smith, 
Szumowski, and Davidson, 1985; Walker, Gerall, and Kostrzema, 1981). 
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Animal Studies 
Clark et al. (1984) reported that yohimbine hydrochloride , an alpha 2 NE 
autoreceptor blocker , significantly increased sexual motivation in male rats . In 
that study, sexually experienced, gonadally intact , male rats were injected 
intraperitoneally with yohimbine (2 mg per kilogram) or vehicle and , twenty 
minutes later, were given a local anesthetic in the genital area. The number of 
mounts during a fifteen minute mating test were then recorded. Sexual motivation 
was assessed by the number of mounts made by the male in the absence of 
feedback from the genitals during the fifteen minute mating test with a sexually 
receptive female. Rats treated with yohimbine displayed significantly more-
mounts during the fifteen minute test than the vehicle treated controls. Based on 
these results, they concluded that yohimbine increased arousal via a blockade of 
alpha 2 autoreceptors which resulted in a potentiation of the postsynaptic action 
of NE. One difficulty with the use of yohimbine in behavioral studies is that , like 
most drugs, it has a complex pharmacological profile. For example, not only does 
it block adrenergic autoreceptors (thereby potentiating NE action) , it also blocks 
5-HT receptors (Gyermek, 1975). Consequently, the facilitation of male sexual 
behavior observed in tt.Ea.t study could quite conceivably have resulted from 
decreased 5-HT postsyr..aptic activity. Indeed, they addressed this issue in their 
paper by stating that future work is needed with more specific adrenergic drugs in 
order to ascertain whether the observed enhancement of male copulatory behavior 
in their study is specific to yohimbine or can be replicated with other 
noradrenergic agents. 
A more recent study by Clark et al. (1985), followed the above approach. Using 
a variety of drugs which exert specific effects on NE receptors, they explored the 
role of NE autoreceptors in masculine sexual behavior. They reported that 
treatment with the anti-hypertensive agent, clonidine (which at low doses 
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preferentially stimulates presynaptic alpha 2 autoreceptors), completely eliminated 
ejaculatory behavior in male rats. Moreover, this effect was completely abolished 
by pretreatment with yohimbine. In that same study, prazosin , an alpha 2 
postsynaptic NE receptor blocker, significantly increased the latency to initiate 
copulation, as well as ejaculation latencies, while having virtually no effect on 
copulatory activity (i.e. mounts , intromissions). Based on these results and their 
previous study, they suggest that the NE neurons play a significant role in the 
regulation of sexual motivation in the rat. 
The role of NE in male copulatory behavior has been further clarified by a 
series of studies by Mcintosh and Barfield ( 1984c ). They report that disruption of 
I\"E-containing neural pathways in sexually experienced male rats by electrolytic 
lesions of the locus coeruleus, or peripheral administration of NE synthesis 
inhibitors , had a profound effect on male copulatory behavior. Following lesions-
to the locus coeruleus, a significant increase in the post-ejaculatory refractory 
period compared to the initial baseline score was observed. Interestingly, 
peripheral administration of diethyldithiocarbamate (DDC) , a NE · synthesis 
inhibitor, increased the post-ejaculatory period and the intromission latency, but 
at the same time reduced the number of intromissions prior to ejaculation 
compared to saline-injected controls. In addition, DDC treatment significantly 
increased the ejaculation latency, while ·having no effect on the percentage of 
animals ejaculating. Based on these results, they propose that since disruption of 
NE-containing neural pathways impairs sexual arousal without affecting other 
parameters of copulatory behavior (e.g. ejaculation), these pathways are critically 
involved in the control of sexual arousal in the male rat. 
Although the Mcintosh and Barfield study indicates a functional role for NE in 
male copulatory behavior, not all studies support this conclusion. For example, 
Clark ( 1980) reported that following neurochemical lesions of the dorsal 
noradrenergic bundle in male rats, no effect was observed on any parameter of 
copulatory behavior, despite the fact that a significant depletion of brain NE was 
found. 
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Human Studies 
Clinical reports suggest that decreased adrenergic activity is associated with 
decreased libido and erectile dysfunction in men (Buffan, 1982). Hoehn-Saric et al. 
(1981) reported that following clonidine treatment in men suffering from anxiety, 
during the first week of treat~ent a substantial number of males reported a 
decrease in sexual desire and a mild difficulty in obtaining an erection. 
Conversely, therapeutic effects on ejaculatio praecox (premature ejaculation) have 
been reported with drugs that block NE receptors (Singh, 1963). Moreover, 
increased NE activity has been postulated to be responsible for spontaneous 
ejaculatior.. associated with a.Lxiety in men (Redmond et al. 1983). 
Summary 
At present, it seems that NE plays a role in male sexual behavior. However, the 
majority of studies that have investigated noradrenergic systems have used 
systemically administered drugs. Therefore, these effects may be due to peripheral 
changes in the sympathetic nervous system. Consequently, further work is needed 
to evaluate the role of adrenergic systems in male sexual behavior following direct 
noradrenergic perturbations in the CNS. 
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ACETYLCHOLINE (ACh) AND MALE SEXUAL BEHAVIOR 
Animal Studies 
In contrast to studies inYestigating the role of monoaminergic systems in 
masculine sexual behavior , there have been comparatively few studies that have 
examined the role of cholinergic mechanisms. In one of the earlier studies, 
Soulairac ( 1963) reported that , following systemic injection of a cholinesterase 
inhibitor, physostigmine, a prolongation of the ejaculation latency and the 
postejaculatory interval (PEl) was found. Soulairac and Soulairac (1972) later 
reported a reduction in ejaculation latencies and in the post ejaculatory interval 
following administration of the ACh receptor .agonist, nicotine. 
More recently, Hull, Bitran, Pehek, Warner, Band, and Bazzett (1986) have 
examined the role of ACh in male sexual behavior following direct injections of a 
ACh antagonist into the preoptic area of male rats. They report that bilateral 
injections of scopolamine produced a dose-related impairment of copulatory 
behavior which was primarily related to disruptions of copulatory mechanisms 
(i.e. percentage of animals intromitting and ejaculating). In that same 
investigation, ventricular injections of scopolamine increased intromission 
latencies, which they interpreted as an impairment of sexual arousal. 
Human Studies 
There is only one report in the literature of sexual dysfunctions associated with 
ACh in man (Forsberg, Gustavii, Hojerbaek, and Olsson, 1979). In that study on 
two male cigarette smokers, nicotine was associated with erectile dysfunction. 
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This is not surprising since nicotine administration has been reported to decrease 
blood flow to the penis (Buffum, 1982). Indeed, in the Forsberg study, they 
reported that penile blood flow was decreased with smoking, and that when 
smoking was discontinued, blood flow was restored, along with erectile capacity. 
THE ROLE OF GAMMA-AMINOBUTYRIC ACID (GABA) 
IN MALE SEXUAL BEHAVIOR 
Animal Studies 
Very recently, attention has begun to focus on the significance of GABA in the 
neural regulation of male sexual behavior. In a study by Fernandez-Guasti; 
Larsson, and Beyer (1986) unilateral injections into the MPOA-AH of GABA 
antagonists (picrotoxin or bicuculline) were reported to dramatically shorten 
ejaculation latencies as well as the postejaculatory interval (PEl) in the 
experimental animals compared to saline-injected controls. The most dramatic 
effect was seen on the PE~: ·where all but one animal resumed copulation within 
one minute after the fir3: ejaculation ! Conversely, compared to a saline injected 
control group, bilatera: 1njections of a GABA agonist (muscimol) into the MPOA-
AH significantly decr~ased the proportion of animals ejaculating during a 60 
minute mating test. An interesting finding was that systemic injections of 
bicuculline, picrotoxin, or muscimol had no effect on male copulatory behavior. 
Since a decrease in GABA activity produced its most dramatic effect on the 
postejaculatory interval, while having little effect on copulatory behaviors (e.g. 
mount and intromission frequencies), or initiation of copulation (intromission 
latency), the researchers concluded that the major function of GABA in male 
copulatory behavior was in determining the interval of sexual inactivity following 
ejaculation. 
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In a contemporary study by Qureshi and Sodersten ( 1986) similar conclusions to 
that of the Fernandez-Guasti et al. study were reached. They measured the 
concentrations of amino acids in the CSF in freely moving male rats immediately 
following ejaculation, and after the PEL They report that the concentration of 
GABA increased by more than 1000 % after ejaculation. Since this is a period 
when sexual behavior is inhibited, they too concluded that GABA may be 
functionally related to the PEL Although an interesting conclusion, interpretation 
of their results is somewhat confounded by the fact that GABA concentrations 
where also high after the PEl, a period characterized by sexual excitation. 
Nonetheless, collectiveiy these studies suggest that GABAergic mechanisms are 
involved in the regulation of male copulatory behavior. 
OPIATES AND MALE SEXUAL BEHAVIOR 
Considerable research has accumulated on the role of opiates in male sexual 
behavior. Most studies indicate that opiates play an inhibitory role in both animal 
(Allen, Renner, and Luin(~ . 1985; Band, Warner, Pehek, Bitran, Holmes, and Hull, 
1986; Gessa ,Paglietti a·.1d PeiJ.egrini-Quarantotti, 1979; Hetta, 1977; Lieblich, 
Baum, Diamond, Goldb~um, Iser, Pick, 1984; Myers and Baum, 1979, 1980; 
Meyerson and Terenius, 1977; Meyerson, 1981; Sachs, Valcourt, and Flagg, 1981; 
Szechtman, Simantov, and Hershkowitz, 1979), and human sexual behavior 
(Cushman, 1972; Deleon and Wexler 1973; Goldstein and Hansteen, 1977; 
Greenberg, 1984; Mendelson, Ellingboe, Keuhnle, and Mello, 1979, 1980; Miran, 
Meyer, Mendelson, and Ellingboe, 1980). For example, peripheral administration 
of morphine has been shown to inhibit copulatory behavior in gonadally intact 
and castrated male rats in doses which fail to reduce motor activity or social 
contact (Mumford and Kumar, 1979; Leiblich et al., 1984). In the majority of 
studies, peripheral injections of low doses of morphine or methadone increase 
intromission and mount latencies, whereas increasingly higher doses eventually 
eliminate copulatory behaviors. 
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Animal Studies 
In one of the earlier studies to investigate the role of opiates in male rat sexual 
behavior, Meyerson and Terenius (1977) reported that, following intraventricular 
injection of B-endorphin (1 ug) the percentage of male rats mounting sexually 
receptive females decreased significantly compared to saline injected controls. 
Moreover, in the males that did initiate mounting, longer latencies were observed. 
The effect of exogenous B-endorphin on male copulatory behavior was completely 
blocked by pre-treatment with the opiate antagonist naltrexone. 
Subsequently, Meyerson (1981), compared the sexual behavior of male rats 
following intraventricular injections of either B-endorphin or morphine to a CSF 
vehicle injected control group. In that study, sexually vigorous male rats were 
castrated and maintai~ed on weekly injections of testosterone propionate which 
resulted in about 7.5 % of the rats mounting receptive females during a 5 minute 
mating test. Although tte lowest dose of B-endorphin (0.25 ug) produced no 
differences on any para::-_L~ ~er of sexual behavior compared to the CSF injected 
controls, 0 . .5 ug and 1 ug significantly decreased the number of mounts and 
intromissions during a 30 minute mating test. Identical doses of morphine had no 
appreciable effect on sexual activity. The author speculated that the observed 
differences in copulatory behavior between the B-endorphin and morphine 
injected groups may have been a reflection of a differential distribution of the two 
opioids in the brain following intraventricular injections. Another explanation 
was the possibility that morphine and B-endorphin are working on different 
opioid receptors. 
In a study by Mcintosh, Vallano, and Barfield {1980) working with the opiate 
antagonist naloxone, they reported a facilitation of male copulatory behavior, but 
suggest an opiate/catecholaminergic interaction. In that study, intraperitoneal 
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administration of naloxone to sexually experienced male rats 30 minutes before a 
mating test with a sexually receptive female, caused a significant reduction in 
mount, intromission, and ejaculation latencies. In addition, they observed a 
significant decrease in the number of mounts preceding ejaculation. Conversely, 
intraperitoneal administration of morphine (6 mg /kg) or intraventricular 
injection of B-endorphin (6 ug) in sexually experienced male rats 30 minutes prior 
to testing completely eliminated copulatory behavior. In that study, they were 
also interested in determining whether the effects of opiates were correlated with 
changes of catecholamine levels in the hypothalamus or corpus striatum. They 
found that the impairment of copulation observed following intraventricular 
injections of B-endorphin was significantly correlated with increased NE content 
in the hypothalamus. In addition, although not significantly different, a trend 
towards increased striatal DA content was found following intraventricular 
injections of both B-endorphin and systemic morphine. Based on the above, they 
suggest that endogenous opiates modulate male copulatory behavior by tonically 
regulating catecholamine release. Indeed, they postulate that the dramatic 
facilitation of male copulatory behavior following injection of opiate antagonists 
results from the ability of these compounds to block the inhibitory effects of 
endogenous opiates on either DA or NE release. 
Similarly, ~1yers and Baum (1980) examined the effects of different doses ( 5 or 
20 mg/kg) of opiate antagonists on male copulatory behavior in sexually 
experienced male rats during a 30 minute mating test. They reported that 
intraperitoneal injections of 20 mg/kg of naloxone or naltrexone, significantly 
reduced the number of intromissions prior to ejaculation and also reduced 
ejaculation latencies, compared to a saline-injected control condition. 
Interestingly, the lower dose of both antagonists significantly shortened both 
mount and intromission latencies, an effect not seen following the higher dose. 
Both doses, however, significantly reduced ejaculation latencies. The authors 
speculated that endogenous opiates may be essential for maintaining a particular 
pattern of copulatory behavior, that ensures successful impregnation of the female 
27 
during a normal mating sequence. This speculation was based on the work of 
Adler (1969) which revealed · that if ejaculation is preceded by too few 
intromissions, pregnancy does not occur. Why the lower dose of the opiate 
antagonists preferentially affected arousal mechanisms, and the higher dose, 
copulatory mechanisms, was not explained. 
In a subsequent study, Lieblich et al. (1984) reported that peripheral injections 
of either naloxone or morphine (5 mg per kilogram) in castrated male rats, 
significantly reduced the percentage of animals ejaculating in a 60 minute mating 
test. In gonadally intact males, however, both naloxone and morphine failed to 
alter copulatory behavior compared to saline-injected controls. The fact that both 
an opiate antagonist and agonist impaired mating in this study was not explained. 
Band et al. (1986) recently examined the role of MPOA-AH opiate systems in 
male rat copulatory behavior. They reported that injection of naloxone ( 1 ug) into 
the "MPOA-AH shortened both ejaculation latency and the postejaculatory 
interval. In addition, injection of 2 ug of morphine significantly decreased the 
proportion of animals ejaculating during a mating test, and lengthened the 
postejaculatory interval. These findings strongly suggest that opiates within the 
MPOA-AH play an inhibitory role in the regulation of masculine sexual behavior. 
Human Studies 
Heroin has long been known to disrupt male sexual behavior. Among heroin 
addicts, there is a progressive decline in sexual behavior and libido associated with 
chronic opiate use. Indeed, in one study, 61 % of heroin addicts reported 
decreased libido, while 39 % reported suffering from impotence which ceased 
following detoxification (Cushman, 1972). In addition, the inability to experience 
orgasm seems to be an inevitable consequence of long term opiate use (Smith, 
Moser, Wesson, Apter, Buxton, Davidson, Orgel, and Buffum, 1982). Interestingly, 
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this is in contrast to retrospective accounts of opiate addicts who often equate the 
drug's effect with heightened sexuality (Mirin et al. 1980). 
Consistent with the above, administration of opiate antagonists seems to 
enhance sexual performance in males. For example, Mendelson et al. ( 1 979a) 
reported that following oral administration of naloxone to seven healthy 
volunteers, three of the seven reported recurrent spontaneous penile erections 1-3 
hours after taking the naloxone. 
Similarly, in a study done with a single subject, the effects on masturbation of 
weekly injections of increasingly higher doses of intravenous naloxone were 
examined (Goldstein and Hansteen, 1977). In that study, naloxone had no effect 
on sexual arousal, penile erection, or ejaculation. In fact, they reported that 
naloxone produced a dose-dependent trend of increased erection latencies. Closer 
examination of their data, however, suggests anot~er interpretation. Granted, 
naloxone did appear to inhibit the ability of the subject to achieve penile erection. 
However, one wonders if this was secondary to a distraction introduced by the 
experimenter: the subject was required to press a buzzer every minute to signal 
that there was no unexpected reaction to the naloxone treatment ! It was not 
clear from examination of the method whether this precautionary measure was 
implemented during the saline condition. Indeed, once an erection had been 
attained following naloxone treatment, there was a reduction of the time required 
for ejaculation compared to the saline condition. 
Not all studies, however, have shown a facilitatory effect of naloxone. 
Examining the effects of endogenous opiates in human male masturbation, 
Graber, Blake, Gartner, and Wilson (1984) administered 20 mg of naloxone 
intravenously to males (n was not reported ) following which they were instructed 
to initiate masturbation and to signal the onset and termination of orgasm. 
Naloxone produced a significant increase in ejaculation latencies when compared 
to the saline-injected controls. In that same study they also measured plasma B-
endorphin levels in male subjects with intravenous catheters under 4 different 
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experimental conditions. The first group was asked to masturbate to ejaculation, 
the second was instructed to masturbate but suppress ejaculation, the third group , 
to perform masturbation-like movements of the wrist, and the last group to do 
nothing. None of the conditions produced any significant changes in plasma B-
endorphin levels at 10, 20, or 30 minutes, although plasma B-endorphin levels 
were significant:y lower at 60 minutes for all the conditions. Although the authors 
did not dismiss the role of opiates in male sexual behavior, they encouraged 
further research be done before any firm conclusions can be made concerning the 
importance of endogenous opiates in human sexual behavior. 
SUMMARY 
The above studies clearly demonstrate that monoaminergic, cholinergic, 
GABAergic, and opiate systems play a role in the neural regulation of male sexual 
behavior in both animals and humans. Administration of neuropharmacological 
compounds that change the activity of these respective systems induce dramatic 
alterations of male sexual behavior. For instance, increasing dopaminergic activity 
seems to produce a facilitation of sexual behavior, whereas decreasing DA activity 
disrupts male sexual behavior in both rats and humans. In the rat, these effects 
seem to be independent of gonadal or adrenal hormone influence. Moreover, with 
regard to DA, recent studies suggest that the facilitatory effects produced by DA 
are partly mediated at the level of the :MPOA-AH. Injections of drugs that 
increase activity at DA synapses in the MPOA-AH have enhanced male rat sexual 
behavior, while injections of the same drugs in other areas of the brain have had 
no effect (Hull et al. 1986). 
With respect to adrenergic and cholinergic systems, both seem to be facilitatory 
in that increasing or decreasing their activity enhances or impairs copulatory 
behavior respectively , although further studies are required to reveal their exact 
role in male sexual behavior. 
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Both GABAergic and endogenous opiate systems seem to play an inhibitory role 
in male sexual behavior. Moreover, they appear to produce this inhibitory effect 
at least partly at the level of the rvfPOA~AH. 
Recently, attention has begun to focus on the role of non-opioid neuropeptides 
in male sexual behavior. Indeed, the fact that immunohistochemical studies 
demonstrate that non-opiate peptides are located in brain nuclei implicated m 
male sexual behavior suggests that they may play a significant role m 
reproductive behaviors. Therefore, the next section will review this evidence 
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THE ROLE OF NEUROPEPTIDES IN 
MALE SEXUAL BEHAVIOR 
Although the relative importance of neuropeptides in the regulation/modulation 
of female sexual behavior is becoming increasingly understood (Bloch , Babcock, 
Gorski , and Micevych, 1987; Dornan, Malsbury , and Penney, 1987; Harlan , 
Shivers , and Pfaff, 1983; Sakuma and Pfaff, 1983), at this point , little is known 
a bout how peptidergic afferents/efferents of the MPOA-AH or other areas 
implicated in male sexual behavior (see figure below) participate in the neural 
control of this behavior. 
Figure 3 
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Schematic representation of some limbic and 
hypothalamic structures implicated in the 
neural control of male sexual behavior. The 
MPOA-AH is represented by the hatched area. 
Another area implicated in male sexual 
behavior is the Bed · nucleus of the Stria 
Terminalis (BnST) indicated by the black 
circle. (o.b.) olfactory bulb; (o.t.) olfactory 
tubercle; (p.c.) prepyriform cortex; (a.c.) 
amygdaloid complex; (v.e.a.) ventral entorhinal 
area. Diagram modified from Malsbury and Pfaff 
(1974). 
32 
As illustrated m the Table below, t he MPOA-AH contains numerous 
neuropeptides. 
TABLK l. Indicate• •o•e of the neuropept idea found 
within the MPOA-AH (a}. . 
PBPTIDE CELLS FIBERS 
-------------------------------------------------------------
Luteinizin' Hormone Releasing 
Hormone (LHRH) 
Chole~ystokinin-8 (CCK-8) 
Substance P (SP) 
Neurotensin (NT) 
Neuropeptide Y (NPY) 
Somatostatin (SS) 
Corticotropin- Releasin' 
Factor (CRF) 
Oxytocin (OXY) 
Vasopressin (VAS) 
Enkephalin (ENK) 
Alpha-Melanocyte Stimulating 
Hormone (A-MSH) 
Thyrotropin-Releasing 
Hormone (TRH) 
Vasoactive Intestinal 
Peptide (VIP) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
• + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Despite the accumulating evidence demonstrating that numerous neuropeptides 
are concentrated in a structure critically involved in the expression of masculine 
sexual behavior, studies examining the role of non-opioid peptides on male sexual 
behavior have been conspicuously lacking. Indeed, at present, only the roles of 
LHRH (Dorsa and Smith, 1980; Moss, Dudley, Foreman, and McCann, 1975; 
Myers and Baum, 1980), and more recently, neuropep tide Y (Clark, Pushpa, 
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Kalra, and Kalra, 1985 ), have been investigated. Moreover , neither peptide has 
been examined at the level of the MPOA-AH. 
Moss et al. (1975) first reported that subcutaneous injections of LHRH (500 ng) 
in sexually experienced , gonadally intact males , significantly reduced intromission 
and ejaculation latencies compared to a saline treated control group. In a group 
of castrated testosterone-deprived males, however , the same dose of LHRH failed 
to have any effect on copulation. 
A similar approach v:as used by Myers and Baum (1980). In that study, 
subcutaneous injec ~~on;;; of 1 ug of LHRH in gonadally intact and castrated 
testosterone trea·~~cd male rats were administered 1.5 hours before a mating test 
with a sexually receptive female. In the gonadally intact animals, LHRH induced 
a significant reduction in ejaculation latencies. No other parameter w~ affected. 
In the castrated group, however, LHRH, while having no effect on ejaculation 
latencies , significantly increased the PEl compared to the saline condition. 
Clark et al. (1985) reported that injections of neuropeptide Y into the third 
ventricle of male rats drastic::::.Jy suppressed male copulatory behavior. Although 
ineffective at the lowest dose, neuropeptide Y virtually eliminated male 
copulatory behavior in rats that were treated with higher doses (0.02, 0.12 , or 0.47 
nM). Although the majority of rats initiated copulation following injections of 
neuropeptide Y into the third ventricle, all sexual activity ceased after one to five 
mounts. The researchers reported that the three effective doses of neuropeptide Y 
also induced feeding in a dose-related manner compared to saline-injected 
controls. Based on these results, they concluded that injections of neuropeptide Y 
into the third ventricle disrupted sexual behavior by imposing a deficit in · sexual 
motivation. Their basis for this conclusion rested on the observation that most 
males initiated copulatory behavior, but seemed unable to sustain a sufficient 
level of sexual arousal to complete the full copulatory sequence. In addition, since 
injections of neuropeptide Y impaired sexual behavior while at the same time 
inducing eating behavior, they further suggested that this peptide may be an 
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endogenous substance which simultaneously inhibits the neural circuitry for male 
sexual behavior while facilitating the circuits that regulate feeding. 
Two other peptides that may play a role in male sexual behavior are substance 
P (SP) and cholecystokinin (CCK). For example, both SP and CCK 
concentrations within the CNS have been shown to be dependent on gonadal 
hormones (Dees and Kozlowski, lg84; Frankfurt, Seigel, Sim and Wuttke, 1g86; 
Micevych, Matt and Go, lg87; Simmerly and Swanson, lg87). Frankfurt et al. 
(lg86) presented data which revealed significantly higher concentrations of CCK 
in the amygdala and lateral septum, as well as MPOA-AH during the estrous 
compared to the proestrous part of the estrous cycle in female rats. As a result, 
they concluded that CCK and SP neuronal systems may play a role in regulating 
hypothalamo-pituitary function, and more interestingly for this study, in steroid-
dependent behaviors. Indeed, in a recent study by Dornan et al. (lg87) it was 
found that intracerebral injections of SP into the mid_brain central gray facilitated 
female sexual behavior in ovariectomized estrogen-treated female rats. 
More relevant to male sexual behavior are the recent findings of a sex difference 
in CCK and SP concentrations in discrete areas of the brain which have been 
implicated in male sexual behavior (Frankfurt et al. , lg85; Micevych et al., lg87). 
For example, Frankfurt et al. (lg85) found significantly higher concentrations of 
CCK in the MPOA-AH, and higher concentrations of SP in the amygdala m 
males as compared to females. Moreover, in a recent study by Dees et al. (lg84), 
a decrease in immunostained SP fibers in the medial amygdala was reported 
following castration of male rats. 
A similar effect of castration on CCK concentrations within the CNS has been 
recently reported by Simerly and Swanson ( lg87). Indeed, recent 
immunocytochemical studies from our laboratory have shown that the SP 
innervation of the medial nucleus of the amygdala and the bed nucleus of the stria 
terminalis is more extensive in the male than in the female rat (Malsbury and 
McKay, 1g86). What the above studies suggest is that some areas of the brain 
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which have been implicated in male sexual behavior (see figure 3) contain higher 
concentrations of both SP and CCK in males than in females. Moreover, it 
appears that both SP and CCK concentrations within brain loci previously 
implicated in male sexual behavior are lowered after castration. Therefore, it is 
conceivable that SP or CCK or both may be involved in the neural control of 
male sexual behavior. 
In summary, the importance of monoamines m the regulation of male and 
female sexual behavior has been clearly demonstrated. Furthermore, the 
significance of neuropeptides in female sexual behavior has received extensive 
experimental investigation. However, at present, only the role of two non-opioid 
peptides in male sexual behavior have been examined. Accordingly, an attempt 
was made in this dissertation to elucidate the roles of SP and CCK in male 
reproductive behavior. The experimental approach involved recording a variety 
of parameters of male copulatory behavior subsequent to intracerebral injections 
of different doses of SP and CCK into the MPOA-AH in sexually experienced 
male rats. 
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GENERAL ·METHODS 
Animals and Surgery: 
Two-hundred and twenty adult Sprague Dawley male rats purchased from 
Charles River Breeding Farms, St. Constant, Quebec, Canada were used in the 
following series of experiments. Animals weighed between 350-475 grams at time 
of surgery. They were housed singly in solid bottom plastic cages (84x48x38 em) 
in a controlled environment at 21 C , with a reversed light cycle (lights off 2:00 
p.m.). Throughout the experiments food and water was available ad libitum. 
Animals were handled daily so as to avoid stress during intracerebral injections. 
Stimulus females of the same strain were ovariectomized under sodium 
pentobarbital (Somnotol) and implanted with silastic capsules containing estradiol. 
Four hours before behavioral testing, these females were injected with 1 mg of 
progesterone subcutaneously to ensure maximum behavioral receptivity. 
Each male was given pre-ope·:a.tive screening tests in which it was placed with a 
fully receptive female on altern;::t,e days until one ejaculation was achieved during 
a 30 minute test. ~~ales wer~ tested on alternate days until they had ejaculated in 
at least two of these tests. Only males that satisfied this criterion were 
subsequently used in the study. Twenty-four hours following the second 
successful pre-operative screening session , each male was anesthetized with 
Somnotol and received a pair of stereotaxically implanted 22-gauge stainless steel 
guide cannulae with inner stylets (28 gauge) (Plastic Products, Roanoke, Va) 
aimed at the .MPOA-AH, using the atlas of Paxinos and Watson ( HJ82)· as a guide. 
The actual coordinates, however , were experimentally determined (AP = -0.2; 
rviL = 3.7-4.0; DV, from dura = 8.7-8.9). Another two groups of animals 
received bilateral cannula placements aimed at the dorsal caudate/putamen or the 
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lateral ventricles. Coordinates for these areas were also experimentally determined 
(AP = -0.2; ~ = 3.5-3.6; DV = 3.5-3.7; AP -0.2; ~ = 1.5; DV = 3.0-3.1; 
respectively). 
Behavioral Testing: 
Three days following surgery (four days in experiments 5-11) males were given a 
post-operative test in which baseline measures were established. Each test lasted a 
maximum of 30 minutes or until one ejaculation followed by an intromission was 
achieved. If a male did not have an intromission within the first 15 minutes, the 
test was terminated and the male re-tested 4 days later. During the baseline 
testing and subsequent peptide injection tests, the following measures of male 
copulatory behavior were recorded on an IBM micro-computer using a software 
program developed by the author for this purpose: 1) number of mounts preceding 
ejaculation, this included the total number of mounts with pelvic thrusting; 2) 
number of intromissions preceding ejaculation; 3) mount latency, the time interval 
between introduction of the female and the first mount; 4) intromission latency, 
time interval between introduction of the female and first intromission; 5) overall 
ejaculation latency, time interval between introduction of the female and first 
ejaculation; 6) adjusted ejaculation latency, latency from first intromission to first 
ejaculation; 7) post-ejaculatory interval, time from first ejaculation to first 
ensmng intromission; 8) inter-copulatory interval, mean interval between 
intromissions, obtained by dividing the overall ejaculation latency by the 
intromission frequency; 9) contact latency, time interval between introduction of 
the female and approach with anogenital contact by the male; 10) number of 
attempts, this included the total number of attempted mounts (the occurrence of 
which is defined as follows: the male approaches the female, grabs her flanks, but 
either the female moves away before the male can actually mount her, or he 
abandons the attempt) before each ejaculation; 11) misdirected mounts, this 
included the total number of mounts with pelvic thrusting but mounting from the 
front or side (off target) of the female before each ejaculation; 12) number of 
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crawls, total number of times the male approaches the female and then crawls 
over her before each ejaculation. In this study, intromissions were defined as 
mounts with pelvic thrusting terminated by a rapid springing dismount followed 
by penile grooming. 
All mating tests took place 2 hours into the dark period of the cycle. Males were 
placed in rectangular test boxes (51L x 38W x 36H em) containing wood chip 
bedding (changed after each test day) 10 minutes prior to introduction of the 
female. This allowed the males a brief period of adaptation. They then were 
removed and injected with either saline or peptide. Immediately following the 
injection the males were placed back into the test box where a fully receptive 
female was introduced. 
All post-operative test sessions were video-taped using a RCA VHS Camcorder 
(model CMR-300). At a later date, the tape of each original test session was 
analyzed using a video cassette recorder under blind conditions. The procedure for 
this was as follows: For each session, an assistant located the animal's 
identification number on the tape. Next, the assistant advanced the tape just past 
the identification number, whereupon the original observer of the live session was 
called into the room and recorded the copulatory behavior on the IBM computer 
in the same ma.::..r .. er as with the original session. This time, however , the observer 
did not know wl::at experimental treatment the animal had received. Inter-
observer reliability coefficients on mount and intromission scores were 
subsequently calculated from the original (live sessions) and blind sessions (taped). 
Intracerebral Injections: 
Each 28 gauge inner cannula was connected to a 2 microliter syringe by a 12 
inch plastic tube. Distilled water was then drawn up the tube until 1 ul of water 
could be reliably drawn and expelled. Following this, 0.5 ul of air was drawn up 
the inner cannula, whereupon the inner cannula was placed in the peptide or 
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saline solution and 1.5 ul of solution was drawn up the inner cannula. During 
injections, movement of the air bubble ensured that the peptide/saline solution 
had actually been injected into the brain. Two sets of microsyringes were used to 
enable consecutive deliveries of the solution into each side of the brain. Solutions 
were injected manually in a volume of 0.3 ul (each side) over a 60 second period. 
The inner cannula was left in place for an additional 60 seconds before 
withdrawal. Aliquots of all peptide and saline solutions were prepared 
immediately before intracerebral injection. 
Histological Analysis: 
Upon completion of data acquisition, all animals were anesthetized with an 
overdose of Somnotol. Brains were subsequently removed and 46 micron sections 
taken using a cryostat. Sections were then stained using cresyl violet and the 
location of each cannula placement verified with a microprojector. 
Data Analysis: 
Inter-obse:·ver reliability coefficients on mount and intromissions frequencies 
between the original test session and the blind session revealed significant positive 
correlations (r = 0.92, p < 0.001; r = 0.96, P < 0.001, respectively) . 
Consequently, scores from the original test sessions were used in the data analysis. 
The rationale for this is straightforward: judgement errors on any of the measures 
were more likely to be made on intromission and mount frequencies. Since errors 
made on these parameters would have a profound effect on other measures (i.e. 
respective latencies, intercopulatory interval) inter-rater reliability coefficients 
were done on these parameters. Based on the results of the inter-rater reliability 
coefficients, it appeared that whether the rater had prior knowledge of the 
experimental condition did not significantly change the results. Therefore, it was 
decided that the original test session scores would be used in the data analysis. 
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For example, the rater had a better viewing perspective during the live sessions. 
Accordingly, it was felt that these scores would perhaps represent a more accurate 
reflection of each copulatory session. 
Unless otherwise stated, all data were analyzed using an analysis of covariance 
(covariate = baseline seores) in a repeated measure split-plot design (Edwards , 
1985), and post hoc analysis done using t-tests on the adjusted means generated 
from the analysis of covariance (Winer , H)78). 
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Experiment 1: The Effects of Intracerebral Injections 
of SP on Male Copulatory Behavior 
There are at present no data to demonstrate whether SP found in the MPOA-
AH plays any role in the neural mediation of male sexual behavior in the rat. 
Nonetheless, SP has been shown to excite neurons Ill the MPOA-AH after 
iontophoretic application (Mayer and MacLeod, 1979). In addition, testosterone, 
which is essential for male sexual behavior, appears to regulate SP concentrations 
within the CNS (Dees and Kozlowski, 1984). Given this information, it is not 
inconceivable that SP may be involved in the neural mediation of male sexual 
behavior in the CNS, and more specifically via an action on MPOA-AH neurons. 
Therefore, the following experiment was designed to investigate the influence of 
exogenous SP on various components of male sexual behavior. 
Material and Methods 
Animals and Surgery: 
Thirty adult male Sprague-Dawley rats (375-450) were used. All animals 
received a pair of stereotaxically implanted guide cannulae aimed at the MPOA-
AH. 
Behavioral Testing: 
In this experiment, when possible, each animal received three post-operative 
tests. The first was a baseline test which took place 3 days following surgery. 
Forty-eight hours later males were either injected with peptide or a saline 
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solution. Four days following the first injection, each animal received a second 
injection of either peptide or saline, depending on what the animal had been 
injected with first. All treatments were counterbalanced. 
Intracerebral Injections: 
Animals were divided into three groups (n=10 each). Two groups received 
either 10 ng or 100 ng of SP / cannula (Cambridge Research Biochemical, lot # 
02075, Sigma Chemicals. lot# 124F-59202) in a volume of 0.3 uljcannula into the 
MPOA-AH, while the other group received acidified saline (same volume). SP 
was dissolved in a vehicle which contained 0.01 N acetic acid, 0.9 % saline with 
the pH adjusted to 6.0 using NaOH. This vehicle was also used in the control 
injections. The rationale for using acidified saline was as follows: i) it helps 
prevent adsorption to glass, and may make the peptide more stable; ii) Hall and 
Stewart (1983) compared behavioral effects of SP dissolved in saline or acidified 
saline injected intraperitoneally in mice. They fvund consistently stronger 
behavioral effects when the SP was dissolved in acidified saline. 
RESULTS 
One major goal in this experiment, and in the series of experiments that follows, 
was to examine the effects of SP injections in animals with relatively 
homogeneous cannula placements. As a result, any animal which did not have 
both cannulae within, immediately dorsal to, or immediately lateral to the 
MPOA-AH was excluded from the data analysis. Of the 30 animals that began the 
experiment, two died before completion of the experiment, and two never satisfied 
criterion at the baseline test session. Histological analysis revealed that of the 
remammg twenty six-animals, twenty five had both cannula tips within the 
previously defined boundary of the MPOA-AH; as a result, data analysis was 
performed on these (25) animals. Figures 4A and 4B illustrate the relative position 
of the bilateral cannula placements within the MPOA-AH of these animals. 
43 (a) 
FIGURE 4A 
Illustration of bilateral cannula placements in 19 males which received injections 
of SP into or near the NfPOA-AH in experiment 1. Each paired bilateral 
placement is identified by a common letter. The numbers identify the figure in 
the Konig and Klippel ( 1963) atlas from which the figures were redrawn. The 
figure in the bottom right hand corner is an illustration or the approximate angle 
or the cannula placements. Abbreviations: ac, anterior commissure; cc, corpus 
callosum; CL, claustrum; CP, caudate/putamen; F, fornix; LV, lateral ventricle; 
MAH medial anterior hypothalamus; NfPOA, medial preoptic area; oc. optic 
chiasm; pvm, periventricular nucleus; SM, stria medullaris thalamus; st, stria 
terminalis. 
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44 (a) 
FIGURE 4B 
Illustration of cannula placements in 6 males which received bilateral injections 
of acidified saline in experiment J. See figure 4A for list of abbreviations. 
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In order to establish whether the copulatory behavior differed in .1nimals that 
had received a given dose of peptide on the first or second administration , an 
analysis of covariance on order was carried out. This analysis · revealed that 
whether an animal received SP on the first or second administration had a 
dramatic effect on most of the behavioral components recorded. The most 
striking effect was seen on mount, intromission, and ejaculation latencies ( F = 
6.6, df, 1,7, P < 0.05; F = 14.3, df, 1,7, P < 0.01; F = 7.5, df, 1,7, P < 0.05 , 
respectively). For example, although ejaculation latencies increased regardless of 
whether the animals received a SP injection on the first or second injection, the 
magnitude of this increase differed dramatically according to the order of 
injection (see figure 5 ). Consequently, subsequent data analysis was done on the 
first injection test session only. 
As can be seen from tables 2 and 3, intracerebral injections of either 10 ng (n = 
g) or 100 ng (n = 10) of SP, or acidified saline (n = 6) into the :MPOA-AH 
dramatically increased most parameters of male copulatory behavior. The 
magnitude of the increase following SP, however, did not differ significantly from 
that following saline on any of the measures recorded. For example, following 
injection of either 100 ng of SP or saline, both ejaculation and intromission 
latencies :..:..creased dramatically; however, the magnitude of the increase was 
similar for both groups. Consequently, no main effect of session was found (F = 
0.76, df = 2,18, P > 0.05; F = 0.41, df = 2,18, P > 0.05). This is also 
illustrated in figures 6 and 7. 
Interestingly, there was a clear though non-significant trend for reduced 
latencies compared to the saline treated controls (see table 2). However, table 2 
also demonstrates that although latencies were lower in the SP compared to the 
saline groups, fewer animals ejaculated following SP injections. 
46 (a) 
FIGURE 5 
Represents the effects of multiple bilateral injections into the rvtPOA-AH on the 
latency to ejaculation in male rats during a 30 minute mating test with a sexually 
receptive female. Lines correspond to standard error of the mean. 
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TABLE 2 
BXPBRIMBNT 1 : LATENCIES (in seconds) 
Effects of injections of saline or SP into the MPOA-AH on male sexual 
behavior. 
Measures (a) 
ML 
Experimental 
Control 
IL 
Experimental 
Control 
EL 
Experimental 
Control 
AEL 
Experimental 
Control 
ICI 
Experimental 
Control 
I ' 
RP 
Experimental 
Control 
Experimental 
Control 
Baseline 
148.7 + 35 
107.2 + 40 
119.5 + 30 
58.0 + 16 
586.5 + 60 
348.9 + 80 
467.4 +58 
299.5 + 29 
46.1 + 4 
38.8 + 5 
320.5 + 22 
294.6 + 33 
100 
100 
Substance P 
Saline 10 ng 100 ng 
387.9 + 115 256.6 + 137 
405.8 + 109 
337.9 + 77 242.0 + 122 
356.7 + 131 
778.4 + 46 837.2 + 180 
978.9 + 200 
440.1 + 64 594.7 + 136 
621.7 + 163 
54.7 + 7 52.4 + 10 
74.5 + 19 
341.0 + 26 310.8 + 20 
325.0 + 37 
44 90 
100 
a) at baseline, all values for the experimental groups are grand 
means. 
All values are given as mean + S.E.M. See text for further 
details. 
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TABLE 3 
EXPERIMENT 1 : FREQURNC IRS 
Effects of intracerebral injections of saline or SP into the MPOA-AH 
on male sexual behavior (a). 
Measures 
MF 
Experimental 
Control 
IF 
Experimental 
Control 
ATTEMPTS 
Experimental 
Control 
CRAWLS 
Experimental 
Control 
MISDIRECTED 
Experimental 
Control 
Baseline 
3.2 + .4 
3.0 + .2 
13.5 + 1.8 
11.0 + 2.0 
1.1 + 0.3 
1.8 + 0.6 
1.4+0.1 
1.1 + 0.4 
2.1 + 0.2 
1.4 + 0.7 
Substance P 
Saline lOng 100ng 
4.7 + 1.4 5.4 + 2.0 
5.5 + 2.0 
15 . 0 + 2.3 17.4 + 3.7 
14.5 + 2.3 
2.5 + 0.9 2.4 + 1.2 
3.3 + 1.1 
5.1 + 1.0 2.5 + 0.3 
1.3 + 0.4 
1.5 + 0.1 2.1 + 0.6 
2.1 + 0.3 
a) at baseline, all values for the experimental groups are grand 
means. 
All values are given as mean + S.E.M. See text for further details. 
49 (a) 
FIGURE 6 
A comparison or the mean ejaculation latency in experiment 1, during baseline 
and injection tests with two different doses of SP or vehicle. Lines represent 
standard error or the mean. 
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50 (a) 
FIGURE 7 
Effects of two different doses of SP on intromission latencies in experiment 1, 
during baseline and injection tests with two different doses of SP, or vehicle. Lines 
represent standard error of the mean. 
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Experiment 2: The Effects of Surgery on Different 
Components of Male Sexual Behavior 
In Experiment 1, forty-eight hours following an initial baseline test ( -!8 hour test 
session), scores of most components of male copulatory behavior were 
dramatically increased following preoptic injections of both saline and SP. 
However, in animals that received a second injection ( 4 days following the first), 
neither SP nor saline produced an increase in scores of a similar magnitude to 
that seen following the first injection (see figure 5). Therefore, it was not clear 
whether the increase in scores observed following the first injections resulted from 
the intracerebral injections per se, a temporary lesion induced by the bilateral 
cannula placements into the MPOA-AH, the interval between the first and second 
post operative test, or a combination of these factors. In order to explore these 
possibilities, measures of male copulatory behavior in a cannula-implanted control 
group were compared with an untreated control group using testing procedures 
identical to those in experiment one. If the effects of bilateral cannula placements 
in the MPOA-AH were disrupting male copulatory behavior during the • 48 hour 
test session •, then one would expect differences between the cannula-implanted 
controls and the untreated controls on the • 48 hour test • . If, however, the test 
interval was a major contributing factor, both the operated and untreated control 
groups would exhibit increased scores. 
Material and Methods 
Animals and Surgery: 
A new group of twenty adult male Sprague Dawley rats (375-425 grams) was 
used. The animals were divided into two groups. One group (n = 10) received a 
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pa1r of stereotaxically implanted guide cannulae aimed at the MPOA-AH 
(cannula-implanted); another group served as untreated controls (no surgery). 
Behavioral Testing: 
Three days following surgery, both groups were gtven a baseline test of male 
copulatory behavior. Forty-eight hours later, each male was tested again. None 
of the males in either group, however, received an intracerebral injection. Data 
from the baseline test and the forty-eight hour test from the cannula- implanted 
group were compared to that of the untreated control group. 
Results 
Of the twenty animals, two died during surgery, one had both cannulae located 
outside the MPOA-AH, and three failed to satisfy criterion at the post-operative 
baseline test. Another died before completion of the data acquisition. That left 
thirteen animals to be included in the data analysis. 
Tables 4 and 5 illustrate that, in animals that had bilaterally implanted 
cannulae in the MPOA-AH (n = 6, see figure 8) scores on all parameters of male 
copulatory behavior increased on the second post- operative test session (although 
only ML,ll.-, and EL's were significantly increased). This was in striking contrast 
to the untreated controls (n = 7): their scores were relatively stable (see table 4). 
The parameters that seemed most affected by surgery were latencies. For 
example, when compared to the cannula-implanted controls, the untreated 
controls had significantly shorter mount, intromission, and overall ejaculation 
latencies (F = 5.73, df = 1,9, P < 0.05; F = 5.66, df = 1,9, P <0.05; F = 
11.00, df = 1,9, P < 0.01, respectively). This is also illustrated in figures 9 
through 11. One interesting observation (see table 4) is that in the untreated 
control group, there appeared to be a prolongation of the refractory period on the 
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2nd test compared to the cannula-treated controls {although not significantly 
different, F = 1.29, df = 1,9, P > 0.05) 
54 (a) 
FIGURE 8 
Summarizes bilateral cannula placements into or near the MPOA-AH in 6 males -
in experiment 2. See figure 4A for a list of abbreviations. 
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TABLB 4 
EXPERIMRNT 2 : LATENCIES (in seconds) 
Effects of bilateral cannula implants into the MPOA-AH on male 
sexual behavior. 
Measures Baseline 2nd Test 
ML 
Cannula-implanted 
Untreated 
129.9 + 19 
141.1 + 20 
391.0 + 125 * 
155. 3 + . -04 -
IL 
Cannula-implanted 
Untreated 
EL 
70.6 + 13 
133.3 + 21 
362 . 2 + 133 
107.7 + 53 * 
Cannula-implanted 
Untreated 
510.5 + 120 
623.7 + 180 
1113.4 + 256 ** 
630.2 + 176 
ARL 
Cannula-implanted 
Untreated 
ICI 
Cannula-implanted 
Untreated 
PEI 
Cannula-imp~anted 
Untreated 
Cannula-implanted 
Untreated 
439.2 + 116 
545.6 + 136 
40.5 + 8 
48.7 + 14 
254.2 + 13 
337.2 + 35 
100 
100 
751.1 + 300 
465.9 + 135 
97.6 + 142 
51. 1 + 21 
291.3 + 42 
445.2 + 70 
66 
80 
All values are given as mean + S.E.M. See text for further 
details. 
* = significantly different from untreated, P < 0.05 
** = significantly different from untreated, P < 0.01 
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TABLB 5 
RXPRRLMBHT 2 : FRBQUBNCIRS 
Effects of bilateral cannula implants into the MPOA-AH on male 
sexual behavior. 
Measures 
Cannula-implanted 
Untreated 
IF 
Cannula-implanted 
Untreated 
ATTBMPTS 
Cannula-implanted 
Untreated 
CRAWLS 
Cannula-implanted 
Untreated 
MISDIRBCTBD 
Cannula-~lanted 
Untreated 
Baseline 
4.2 + 3.9 
3.8 + 1.9 
12.5 + 3.1 
12.6 + 2.4 
1.0 + 0 
1.6 + 0.2 
1.0 + 0.2 
1.1 + 0.2 
1.0 + 0.3 
3.6 + 0.6 
2nd Test 
4.5 + 2.3 
4.3 + 1.5 
. -- . -
13.0 + 7.7 
11.0 + 2.2 
1.0 + 0.1 
1.5 + 0.5 
2.0 + 0.1 
1.3 + 0.3 
1.2 + 0.1 
2.5 + 0.2 
All values are given as mean + S.R.M. See text for further 
details. 
57 (a) 
FIGURE g 
A comparison of the mean mount latencies in experiment 2, between bilaterally 
implanted (no injection) controls (MPOA- AH), and untreated (no surgery) 
controls displayed over two baseline tests (30 minutes) with a receptive female. 
Lines represent standard error of the mean. Asterisk indicates significantly 
different from the cannula-implanted control group. 
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58(a) 
FIGURE 10 
Sho'NS the mean intromission latencies between cannula- implanted and 
.untreated controls displayed over two baseline tests with a sexually receptive 
female in experiment 2. Asterisk indicates significantly different from controls. 
Lines correspond to standard error of the mean. 
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59 (a) 
FIGURE 11 
Comparison of the effects of bilateral cannula placements in the MPOA in 
experiment 2, on ejaculation latencies over two baseline test with that of an 
untreated control group. Asterisks indicate significantly different from cannula-
implanted group. Lines indicate standard error of the mean. 
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Experiment 3: The Effects of Injections of SP into the 
Caudate/Putamen on Male Sexual Behavior 
The preceding experiment demonstrates that bilateral cannula placement into 
the MPOA-Afl had detrimental effects on male copulatory behavior 48 hours 
following an initial post-operative baseline test. Consequently, experiment 3 was 
designed to explore whether these effects were specific to the MPOA-AH. For 
example, if stereotaxic surgery itself was affecting male copulatory behavior on 
the forty-eight hour test, then one would expect similar increases of measures of 
male copulatory behavior following bilateral cannula implants in another area of 
the brain. Since the caudate/putamen has been suggested to play a role in male 
sexual behavior (Caggiula, Shaw, Antelman, and Edwards, 1976; Hull, Bitran, 
Pehek, Warner, Band, and Holmes, 1986), another group of males were 
stereotaxically implanted with bilateral cannulae into the caudate/putamen (CP). 
In experiment 1, bilateral cannula placement into the MPOA-AH disrupted 
copulatory behavior regardless of whether the animals had been injected with SP 
or saline. This was supported by the findings in experiment 2 which revealed that 
bilateral cannula f)lacement into the MPOA-AH was impairing male copulatory 
behavior. Accordingly, the purpose of experiment 3 was twofold: firstly , to 
compare the effects on male copulatory behavior observed in experiment 1 
following intracerebral injections of SP into the MPOA-AH to that of another 
brain site (CP). Secondly, to evaluate whether SP had a functional role in 
masculine sexual behavior at the level of the CP by examining the effects of SP 
injections into the caudate/putamen on male copulatory behavior 48 hours 
following a baseline test. 
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Material and Methods 
Animals and Surgery: 
A new group of 10 adult male Sprague Dawley rats (380-440 grams) was 
included in the experiment. Each animal received a pair of stereotaxically 
implanted guide cannulae aimed at the dorsal caudate/putamen. 
Behavioral Testing: 
Beginning three days after stereotaxic surgery, each animal was gtven a post-
operative baseline test. Forty-eight hours later, the males were injected with lO-
ng SP / .3 ul bilaterally. 
Intracerebral Injections: 
Identical to that of Experiment 1. 
Results 
Of the ten animals that began the experiment, nme had both cannulae located 
within the dorsal caudate/putamen. However, one died before completion of data 
acquisition, another was sick on the second test session , and one failed to satisfy 
criterion at the baseline test. Data from the remaining 6 animals were analyzed. 
Figure 12 is representative of bilateral cannulae placements in these animals. 
As can be seen in tables 6 and 7, an analysis of covariance revealed that, when 
compared to both the saline and SP (10 ng) injected animals in Experiment 1, the 
caudate group differed on most parameters of male copulatory behavior. This 
62(a) 
FIGURE 12 
Is an illustration of a representative bilateral cannula placement into the dorsal 
caudate/putamen in males which received injection of 10 ng of substance P in 
experiment 3. The number in the right top corner identifies the figure in the 
Konig and Klippel (lg63) atlas from which the figure was redrawn. Abbreviations: 
ac, anterior commissure; cc , corpus callosum; CPu, caudate putamen; f, fornix; 
GP , globus pallidus; ic , internal capsule; MPOA, medial preoptic area; oc , optic 
chiasm; 3V third ventricle. 
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TABLB 6 
RXPRRIMKNT 3 : LATB.NCIRS (in seconds) 
Effects of injections of saline or SP into either the MPOA-AH, or 
the caudate/putamen on male sexual behavior. 
Measures 
ML 
MPOA-AH 
Caudate 
MPOA-AH 
IL 
MPOA-AH 
Caudate 
MPOA-AH 
BL 
MPOA-AH 
Caudate 
MPOA-AH 
ABL 
MPOA-AH 
Caudate 
MPOA-AH 
ICI 
MPOA-AH 
Caudate 
MPOA-AH 
PHI 
MPOA-AH 
Caudate 
MPOA-AH 
MPOA-AH 
Caudate 
MPOA-AH 
Baseline 
107.2 + 40 
149.4 + 16 
212.6 + 53 
58.0 + 16 
71.0 + 18 
152.2 + 70 
348.9 + 80 
417.8 + 126 
586. 1 + 45 
229.5 + 29 
358.5 + 43 
675.9 + 59 
38.8 + 5 
45.6 + 6 
47.7 + 6 
294.6 + 33 
290.0 + 15 
352.6 + 43 
100 
l OO 
100 
Saline 
405.8 + 109 
356.7 + 131 
978.9 + 200 
621.7 + 163 
74.7 + 19 
325.0 +37 
100 
Substance P (10 ng) 
82.1 + 46 
388.-3 + 64 * 
75.7 + 26 ** 
338.6 + 115 
506.0 + 50 
777.5 + 43 
506.2 + 55 
440.1 + 63 
31.1+2.3 
55.1 + 7 
339.3 + 27 
340.0 + 36 
100 
44 
* 
All values are given as roean + S.E.M. See text for further 
details. 
* = P < 0.05, caudate vs MPOA-AH injections. 
-..-.. ;; P ~ 0 • 01 (;C'UJUct tQ VS MPO&· .A 'l 1 nj ~c; t \ ~n' 
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TABLR 7 
RXPRRIMRNT 3 : FRBQUBNC IRS 
Effects of intracerebral injections of saline or SP into either 
the MPOA-AH, or the caudate/putamen on male sexual behavior. 
Measures Baseline Saline Substance P (10 ng) 
MF 
MPOA-AH 2.6 + .7 5.6 + 3 
Caudate 2.3 + l 3.6 + 1 
MPOA-AH 3.2 + .8 4.7 + 1.2 
IF 
MPOA-AH 9.6 + 1.2 14.5 + 3 
Caudate 9.5 + 1.6 16.0 + 5.9 
MPOA-AH 18.0 + 2.8 15.0 + 4.6 
ATTEMPTS 
MPOA-AH 1.8+ 0.4 3.3 + 0.9 
Caudate 1.6+ 0.1 1.0 + 0.9 
MPOA-AH 1.3 + 0.3 2.5 + 0.4 
CRAWLS 
MPOA-AH l.l + 0.1 1.3 + 0.2 
Caudate 1.0 + 0.3 1.3 + 0.1 
MPOA-AH 1.4 + 0.1 1.5 + 0.5 
MISDIRECTED 
MPOA-AH 1.0+ 0.1 1.0 + 0.2 
Caudate 1.3 + 0.2 l.l + 0.3 
MPOA-AH 1.6 0.1 1.3 + 0.2 
All values are given as mean + S.E.M. See text for further 
details. 
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difference was not the result of a SP-induced facilitation following caudate 
injections, since post hoc analysis using a multiple comparison t-test revealed no 
significant difference between the first and second test sessions in the SP injected 
caudate group. Therefore, it appeared that the main effect of condition was 
primarily the result of an increase in scores on the second test in the .MPOA-AH 
injected groups. This is illustrated in figures 13 and 14. Again, the most dramatic 
effects were on latencies where mount, intromission, and ejaculation latencies of 
the Caudate group differed significantly from the other two groups (F = 4.9 , df, 
2,15, P < 0.05; F = 3.9, df, 2,15, P < 0.05, F = 5.3, df = 2,15, P < 0.01, 
respectively). 
66 (a) 
FIGURE 13 
Comparison of mean ejaculation latencies in males in experiment 3, during 
baseline tests and injection tests of SP or vehicle into the MPOA, or into the 
caudate/putamen. Asterisk indicates significantly . different from MPOA-AH 
groups. Lines represent standard error of the mean. 
20 ~ 
18 ~ 
16 -
14 ~ 
12 ~ 
....._ 
~ 
ca 
~ 
::I 
c: 10 -
-E 
-- 8 ..;. 
...., 
E 
-t- 6 ~ 
EJACULATION 
LATENCY 
66 (b) 
/ 
/ 
SALINE 
..1111111111.. 
/ 
/ SP 
// ,"' ~ (MPOA-AH) 
/. "' I 
,;'/ 1"'"' 
I ,,"' // 
• ,"' // * I SP 
~ // - --- II (CAUDATE) / ----_,_--/ 
/ 
i 
t I 
Baseline Injection 
67 (a) 
FIGURE 14 
Mean intromission latency between :MPOA-AH groups and caudate/putamen 
group in experiment 3 , during baseline and injection tests with SP or vehicle. 
Asterisks indicate significantly different from the MPOA-AH injected groups. 
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Experiment 4: Test Interval 
It was clear from the results of Experiment 2 that , in animals with bilateral 
cannulae within the previous defined boundaries of the MPOA-AH, a second post-
operative test 48 hours following an initial baseline test produced dramatic 
mcreases in most of the temporal measures of male copulatory behavior. 
Moreover ,it appeared from Experiment 3 that this was specific to the rv!POA-AH, 
in that neither surgery itself nor SP injections into the dorsal caudate/putamen 48 
hours after the first post-operative test had any appreciable effect on male 
copulatory behavio:. Thus it appears that the timing of the post-operative tests 
interacts with the effects of MPOA-AH cannula implants to produce decrements 
in male copulatory behavior. Consequently, in Experiment 4, different intervals 
between the first and second post-operative test were assessed in order to 
determine an interval that would produce relatively stable first and second post-
operative scores in animals with rv!POA-AH cannulae. 
Material and Methods 
Animals and Surgery: 
A new group of ten adult male Sprague Dawley rats (3g0-425 grams) began the 
experiment. Each animal received a pair of bilaterally implanted guide cannulae 
aimed at the MPOA-AH. 
Behavioral Testing: 
The following post-operative intervals were assessed in order to establish 
relatively stable post- operative scores between post-operative tests: A) First test 3 
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days post-surgery, second test 7 days post- surgery (n = 3); B) first test 4 days 
post-surgery, second test 8 days post-surgery (n = 3); C) first test 4 days post 
surgery, second test g days post-surgery (n = 4). During this experiment, no 
intracerebral injections were made. 
Results 
As can be seen from tables 8 through 13 four days post-surgery (1st test) and 5 
days following the 1st testing (9 days post-surgery), produced relatively stable 
scores on all components of male copulatory behavior. Accordingly, the post-
operative interval from condition • C • was used in all subsequent experiments. 
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TABLE 8 
EXPERIMENT 4 : LATENCIES (in seconds) 
Post-operative test interval which produced relatively 
stable measures of male sexual behavior in animals with 
bilateral cannula implants into the MPOA-AH. 
Measures 
ML 
IL 
EL 
AEL 
ICI 
PEI 
% E 
4 days 
post surgery 
125.3 + 38 
134.2 + 41 
788.2 + 145 
671.2 + 126 
51.6 + 3 
304.6 + 28 
100 
9 days 
post surgery 
138.7 + 26 
104.2 + 60 
698.6 + 156 
590.1 + 186 
43.4 + 10 
329.8 + 22 
100 
All values are given as mean + S.E.M. See text for further 
details. 
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TABLE 9 
BXPRRIMBNT 4 : FRBQUBNCIRS 
Post-operative test interval which produced relatively 
stable measures of male sexual behavior in animals with 
bilateral cannula implants into the MPOA-AH. 
Measures 
4 days 
post surgery 
9 days 
post surgery 
MF 
5.1 + 1 4.6 + .6 
IF 
13.2 + .6 11.3 + .2 
ATTRMPTS 
1.3 + .. 2 1.0 + . 1 
CRAWLS 
1.1 + .5 1.4 + .3 
MISDIRECTED 
1.6 + .7 1.3 + .9 
All values are given as mean + S.E.M. See text for further 
details. 
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TABLE 10 
EXPERIMENT 4 LATENCIES (in seconds) 
Post-operative interval that did not produce stable baseline 
scores of male sexual behavior in animals with bilateral 
cannulae implanted into the MPOA-AH 
Measures 
ML 
IL 
EL 
AEL 
ICI 
PEI 
% E 
3 days 
post surgery 
157.3 + 22 
111.2 + 49 
912.5 + 132 
801.3 + 100 
53.0 + 3 
434.1 + 43 
100 
7 days 
post surgery 
167.9 + 44 
141.2 + 28 
951.3 + 200 
810 . 1 + 121 
57.3 + 7 
400.0 + 16 
66 
Al l values are expressed as mean+ S.E.M. See text for details. 
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TABLE 11 
EXPERIMENT 4 FREQUENCIES 
Post-operative interval that did not produce stable baseline 
scores of male sexual behavior in animals with bilateral 
cannulae implanted into the MPOA-AH 
Measures 
MF 
IF 
ATTEMPTS 
CRAWLS 
MISDIRECTED 
3 days 
post surgery 
7.3 + 2 
15.1 + 2 
1.2 + .1 
1.9 + .1 
1.5 + .3 
7 days 
post surgery 
6.9 + 1 
14.2 + 1 
1.0 + .2 
1.1 + .1 
2.0 + .5 
All values are expressed as mean+ S.E.M. See text for details. 
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TABLE 12 
EXPERIMENT 4 LATENCIES (in seconds) 
Post-operative interval that did not produce stable baseline 
scores of male sexual behavior in animals with bilateral 
cannulae implanted into the MPOA-AH 
Measures 
ML 
IL 
EL 
AEL 
ICI 
PEI 
% E 
4 days 
post surgery 
127 . 3 + 32 
140.1 + 59 
812.5 + 122 
640.9 + 111 
50.4 + 5 
404.1 + 23 
8 days 
post surgery 
147.9 + 34 -
121.2 + 48 
901.3 + 212 
678.1 + 151 
74.1 + 1 
378.6 + 26 
100 100 
All values are expressed as mean+ S.E.M. See text for details. 
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TABLE 13 
EXPERIMENT 4 FREQUENCIES 
Post-operative interval that did not produce stable baseline 
scores of male sexual behavior in animals with bilateral 
cannulae implanted into the MPOA-AH 
Measures 
MF 
IF 
ATTEMPTS 
CRAWLS 
MISDIRECTED 
4 days 
post surgery 
4.3 + 2 
16.1 + .1 
1.0 + .1 
1.1 + .1 
1.3 + .0 
8 days 
post surgery 
5.6 + 1 
12 . 2 + .3 
1.1 + .1 
1.2 + .1 
1.0 + .1 
All values are expressed as mean+ S.E.M. See text for details. 
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DISCUSSION: EXPERIMENTS 1 THROUGH 4 
In the .J receding experiments , it was revealed that eit her SP or saline injected 
bilaterally into the MPOA-A.H forty- eight hours after an initial baseline test 
increased scores on most parameters of male copulatory behavior . This increase , 
however , seemed to be a result of an interaction between the MPOA-AH cannula 
implan ts and the interval between the first and second test session rather than the 
injections per se. This may have been the result from a temporary lesion induced 
by the bilateral cannulae into the rv!POA-AH, as surgery to the dorsal 
caudate/putamen had no effect on male copulatory behavior forty-eight hours 
following the baseline test, nor were any increases observed in the untreated 
controls in Experiment 2. Indeed, the copulatory behavior observed in some -
animals during the second post-operative test in Experiment 1 closely resembled 
the pattern of behavior seen in animals following lesions of the rv!POA-AH. For 
example , these animals would invariably approach the female, sniff the anogenital 
region , pursue her , have numerous mounts , yet be apparently unable to carry out 
t he full copulatory sequence. 
Although both groups demonstrated . disrupted male copulatory behavior 
patterns, there were a number of distinct differences between the saline and the 
SP-injected groups. Firstly, although scores in both groups increased dramatically 
on the second post-operative test, in the SP groups , mount, intromission ,· as well 
as ejaculation latencies, were lower compared to the saline injected controls. In 
fact, there was a trend for a dose-related decrease on mount and intromission 
latencies in the SP groups compared to the saline group on the second post-
operative test (see table 2). Secondly, in Experiment 1, a marked increase in the 
frequency of • crawls • was observed in both SP groups but not in the saline 
controls (see table 3). For instance, on numerous occasions, males in the SP group 
would pursue the female, mount and grab the flank region, but instead of an 
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intromission, would crawl over the fe1nale. This is particularly revealing in that 
this type of behavioral pattern has been referred to as • displacement • , and is 
believed to reflect a form of sexual frustration (Hansen and Hagetarum, 198-t). 
This type of behavior pattern was rarely observed in the saline injected controls. 
Given this, it is not inconceivable that in Experiment 1, SP could have been 
producing a facilitation of male copulatory behavior, but due to the temporary 
lesion, animals were not able to copulate. 
Accordingly, Experiments 5 through 10 were designed to re-evaluate the role of 
SP on male sexual behavior using the new post-operative test schedule established 
in Experiment 4. 
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Experiment 5: The Effects of Three Different Doses 
of SP on Male Copulatory Behavior 
Material and Methods 
Animals and Surgery: 
Forty .-:..dult male Sprague Dawley rats (375-450 grams) were used. All animals 
received a pair of stereotaxically implanted guide cannulae aimed at the MPOA-
AH. 
Behavioral 'Testing~ 
A.s per the general methods, with one exception: since it was possible that more 
animals would have ejaculated in Experiment 1 if the test duration had been 
longer, the test session was increased to 40 minutes. 
Intracerebral Injections: 
Animals were divided into four groups. Three groups received either 10 ng, 100 
ng, or 200 ng of SP /cannula dissolved in acidified saline in a volume of 0.3 ul into 
the MPOA-AH, while the remaining group received acidified saline. 
Results 
Of the 40 animals that began the experiment, two did not complete data 
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acquisition (sickness, cannula blocked ), one had both cannulae located outside the 
rvfPOA-AH, and four didn't satisfy criterion at the post-operative baseline test. 
That left thirty-three animals for data analysis (controls, n = 8; 10 ng SP, n = 8; 
100 ng SP, n = 6; 200 ng SP, n = 11). Figure 15A and 15B illustrate the location 
of the cannula placements within the rvfPOA-AH of these animals. 
Tables 14 and 15 demonstrate that bilateral injections of SP into the MPOA-AH 
facilit~_ted male copulatory behavior. This was revealed by a significant main 
effect (followed by post hoc analysis using a multiple comparison t-test) on 
intromisslon latencies (F = 5.78, df - 3,27, P < 0.01), both measures of 
ejaculation latency (F = ·4.60, df = 3,27, P < 0.01; F = 3.3, df = 3,27, P < 
0.05), and the post-ejaculatory refractory period (F = 3.2, df = 3,27, P < 0.05). 
With regard to frequencies, mount frequencies were significantly decreased by 
bilateral injections of all three doses of SP (F = 3.48, df = 3,27, P < 0.05). sp· 
injections did not, however, facilitate male copulatory. behavior in a linear-related 
fashion. For example, although .100 ng of SP had the greatest effect on latencies, 
the 200 ng dose was the least effective (see table 14). This is also illustrated in 
figures 16 and 17. Again, the most dramatic effect was the shortening of latencies 
( ~ ·~e table 14). 
_-\s can be seen from tat_~ 14, a marked decrease in the inter-copulatory interval 
was also produced by SP injections; initially, however, an analysis of covariance 
failed to reveal a significant main effect of condition (F = 1.87, df = 3,27, P > 
0.05 ). In a textbook on statistical design in psychological research, Edwards ( 1g85) 
discusses the problem of heterogeneity of variance when time is a dependent 
variable. He suggests that if there are a few extreme measures, heterogeneity of 
the variance may occur. When this is the case, he advocates transforming the 
data into their respective reciprocals in order to make the variances more 
homogeneous. Therefore, a reciprocal transformation was done and the data re-
analyzed using an analysis of covariance. After reciprocal transformation of the 
raw data, a significant main effect on ICI by condition was found (F = 2.82, df = 
3,27, p < 0.05). 
80 (a) 
FIGURE 15A 
Summarizes bilateral cannula placements in 25 males which received inj ections_ 
of three different doses of SP into or near the MPOA-AH in experiment 5. Letters 
which have a number attached indicate corresponding number of animals with an 
approximately similar cannulae placement. 
80 (b) 
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FIGURE 15B 
Illustration of bilateral cannula placements m 8 animals which received 
injections of acidified saline in experiment 5. 
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TABLR 14 
EXPERIMENT 5 : LATENCIES (in seconds) 
Effects of injections of saline or SP into the MPOA-AH on male sexual behavior. 
Measures (a) 
ML 
Experimental 
Control 
IL 
Experimental 
Control 
EL 
Experimental 
Control 
ABL 
Experimental 
Control 
ICI 
Experimental 
Control 
PEl 
Experimental 
Control 
' . 
Experimental 
Control 
Baseline 
224.5 + 41 
181.6 + 47 
168.7 + 40 
181.9 + 49 
Saline 
147.9 + 23 
206.3 + 42 
Substance P 
10 ng 100 ng 200 ng 
99.5 + 28 67.0 + .6 124.5 + 36 
57.1 + 16** 33.8 + .4** 107.0 + .4** 
950.9 + 140 438.4 + 82** 267.5 + 110** 630.7 + 130 
810.9 + 141 911.9 + 184 
801.4 + 139 380.8 + 72* 245.8 + 200* 524.2 + 100 
629.3 + 106 705.8 + 174 
57.3 + 6 
49.2 + 8 
308.3 + 22 
289.4 + 19 
100 
100 
55.3 + 5 
347.6 + 20 
100 
36.5 + 5* 32.3 + 10* 43.2 + 8 
294.7 + 14 283.0 + 32* 324.9 + 25 
100 83 100 
a) at baseline, all values for the experimental group are grand means. 
All values are given as mean + S.E.M. 
* = P < 0.05, significantly different from controls. 
** : p ( 0.01 II II II II 11 
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TABLE 15 
EXPERIMENT 5 : FREQUENCIES 
Effects of injections of saline or SP into the MPOA-AH on male sexual behavior. 
Measures (a) 
MF 
Experimental 
Control 
IF 
Baseline 
6. 0 + . 3 
4.1 + .5 
Saline 
6.1 + 1.3 
Substance P 
10 ng 100 ng 200 ng 
1.8 + .6 * 2.1 + .7 * 3.5 + .9 * 
Experimental 
Control 
17.4 + 2.3 
15.5 + 3.1 
11.5 + 1.3 8.9 + 1.2 * 14.5 + . 9 
ATTEMPTS 
Experimental 
Control 
CRAWLS 
Experimental 
Control 
MISDIRECTED 
Experimental 
Control 
1.1 + 0.1 
1.3 + 0.2 
1.0 + 0.1 
1.0 + 0 
1.0 + 0.1 
1.0 + 0.1 
16.2 + 2.6 
1.1 + 0.1 1.2 + 0.2 1.3 + .2 
1.2 + 0.3 
1.1 + 0.2 1.0 + 0 1.1 + 0.1 
1.0 + 0.1 
1 . 5 + 0 . 1 -- 1 . 0 + 0 2.0 + 0.3 
2.0 + 0.2 
a) at baseline, all values for the experimental group are grand means. 
All values are given as mean + S.E.M. See text for further details. 
* = P < 0.05, significantly different from controls. 
** = p < 0. 01 It It It " It 
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FIGURE 16 
Illustrates the proportional change of ejaculation latencies from a baseline tes~ 
session (no treatment) in animals which received three different doses of SP, or 
vehicle into the J\1POA-AH in experiment 5. 
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85(a) 
· FIGURE 17 
Illustrates the proportional change of intromission latencies from a baseline test 
(no treatment) in animals which received three different doses of SP, or vehicle 
into the MPOA-AH in experiment 5. 
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Experiment 6: Bilateral Injections of SP into 
the Caudate/Putamen and its Effects on 
Male Copulatory Behavior 
In experiment 3, bilateral injections of 10 ng SP into the Caudate/Putamen had 
no appreciable effect on male copulatory behavior. It is possible that different 
results would have been observed in experiment 3 if the interval between the first 
and second post-operative test had been different. After all, SP injections into 
the .MPO):..-AH produced a facilitation of male sexual behavior in the preceding 
experimenc, but not in experiment 1. These different outcomes are attributed to 
the use of longer post-operative test intervals beginning with experiment 5. 
Therefore, the possible role of SP in the caudate/putamen on male sexual 
behavior was re-evaluated using the new post-operative schedule established in 
experiment 4. 
Material and Methods 
Animals and Su:rgery: 
Ten adult male Sprague Dawley rats (425-485 grams) were used. All animals 
received a pair of stereotaxically implanted guide cannulae aimed at the dorsal 
caudate/putamen. 
Behavioral Testing and Intraeerebral Injections: 
Methods were identical to those of Experiment 5. All animals received bilateral 
injections of 10 ng SP. 
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Results 
One animal did not have both cannulae in the dorsal caudate/putamen (one 
cannula was embedded in the anterior commissure). Data from the remaining g 
animals were analyzed. 
As can be seen from tables 16 and 17, statistical analyses using a paired t-test 
revealed that bilaterat bjections of 10 ng of SP failed to significantly alter any 
parameter of male sexuai behavior. For example, in contrast to experiment 5, no 
effects wer2 seen on mount, intromission, or ejaculation latencies (t = 1.05, df = 
8, P > O.Oti; t = O.Q5, df = 8, P > 0.05; t = 1.57, df = 8, P > 0.05, 
respectively). In addition, 
injections of SP had no appreciable effect on mount or intromission frequencies 
(t = 1.35, df = 8 , p > 0.05; t = 1.21, df = 8 p > 0.05). 
88 
TABLE ·16 
EXPERLMENT 6 : LATENCIES (in seconds) 
Effects of injections of 10 ng SP into the dorsal caudate/putamen 
on male behavior. 
Measures Baseline 
ML 
87.5 + 10 
IL 
83.0 + 7 
EL 
623.0 + 34 
ABL 
516.5 + 25 
ICI 
40.5 + 3 
PBI 
I • 319.2 + 10 
100 
Injection 
Test 
77.1 + 5 
73.4 + 6 
568.1 + 31 
493.0 + 45 
44.6 + 2 
331.1 + 8 
100 
All values are given as mean + S.E.M. See text for further 
details. 
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TABLB 17 
BXPBRIMBNT 6 : FRBQUBNC IBS 
Effects of injections of 10 ng SP into the dorsal caudate/putamen 
on male behavior. 
Measures Baseline 
MF 
5.0 + .2 
IF 
11.5 + .6 
ATTEMPTS 
1.7+ .2 
CRAWLS 
-
. -- . 
1.6+ • 2 . 
MISDIRECTED 
1.4 + .2 
Injection 
Test 
4.4 + .3 
10.7 + .7 
1.3 + . 1 
1.2+ . 1 
1.3+ . 1 
All values are given as mean + S.E.M. See text for further 
details. 
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Experiment 7: The Effects of Bilateral Injections of SP 
into the Lateral Ventricles on Male Copulatory Behavior 
The results of experiment 5 revealed that bilateral injections of SP into the 
~OA-AH facilitated male copulatory behavior. This strongly suggests that SP, 
acting on MPOA-AH neurons, modulates the male's initiation of copulation, as 
revealed by dramatic decreases in copulatory latencies. There is, however, 
another interpretation. The MPOA-AH lies in close contact with the ventricular 
circulation, therefore it is possible that SP injected into the MPOA-AH may have 
leaked out into the cerebrospinal fluid and, as a result, produced its effects on 
another site in close contact with the ventricular circulation. Consequently, 
experiment 7 was designed to explore this possibility by injecting SP bilaterally 
into the lateral ventricles. If the effects of SP on male copulatory behavior 
observed in Experiment 5 were produced at another site via leakage into the 
ventricular circulation, then similar results would be expected following bilateral 
injections of SP into the lateral ventricles. Since 10 ng of SP produced the most 
consistent effects in Experiment 5, this dose was used in the following experiment. 
Methods and Materials 
Animals and Surgery: 
Ten adult male Sprague Dawley rats (380-425 gm) were used. Each animal 
received a pair of stereotaxically implanted guide cannulae aimed at the lateral 
ventricles. 
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Behavioral Testing: 
As per general methods section. 
Intracerebral injections: 
All animals received bilateral injections of 10 ag SP in a volume of 0.3 
uljcannula (Sigma Chemicals, lot # 124F-59203) dissolv~d in 0.01 N acetic acid, 
0.9% saline with the pH adjusted to 6.0. 
Results 
or the ten animals that began the study, two had either one or both cannulae 
located outside the lateral ventricles, and one died during surgery. This left 7 
animals that had both cannulae located within the lateral ventricles (see figure 18 
for a representative cannula placement). Only data from these 7 animals were 
analyzed. Data from these animals were compared to the data of the dorsal 
caudate/putamen injected animals in experiment 6 using an analysis of 
covariance. As dem0nstrated in tables 18 and 19, bilateral injections of SP into 
the lateral ventrici2s significantly reduced the number of intromissions prior to 
ejaculation (F = 15.6, df = 1,15, P < 0.01), and at the same time lengthened 
both mount latencies and the inter-copulatory interval (F = 10.4, df = 1_,15, P < 
0.01; F = 5.6, df = 1,15, P < 0.05, respectively). No other measures were 
affected. 
92(a) 
FIGURE 18 
Represents cannula placements into the lateral ventricles m experiment 7. See 
legend of figure 11 for a more detailed description. 
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TABLE 18 
EXPBR~~NT 7 : LATENCIES (in seconds) 
Effects of injections of SP (10 ng/cannula) into the dorsal 
caudate/putamen or into the lateral ventricles on male sexual behavior. 
Measures 
ML 
Ventricles 
Caudate 
IL 
Ventricles 
Caudate 
EL 
Ventricles 
Caudate 
ABL 
Ventricles 
Caudate 
ICI 
Ventricles 
Caudate -
PBI 
Ventricles 
Caudate 
. ~ B 
Ventricles 
Caudate 
Baseline 
194.6 + 49 
87.5 + 10 
125.2 + 69 
83.0 + 7 
703.2 + 323 
623 + 34 
577.2 + 295 
516.5 + 25 
56.1 + 6 
40.5 + 3 
285.5 + 36 
319.5 + 19 
100 
100 
Substance P (10 ng) 
132.1 + 19 ** 
77.1 + 5 
117.7 + 59 
73.4 + 6 
552.1 + 151 
568.1 + 31 
444.3 + 133 
493.0 + 45 
71.9 + 23 * 
44.6 + 2 
292.1 + 34 
331.1 + 8 
100 
100 
All values are given as mean + S.B.M. See text for further details. 
* = P < 0.05, significantly different from caudate group. 
** = p < 0.01 " " " " " 
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TABLE 19 
EXPERIMENT 7 : FREQUENCIES 
Effects of injections of SP (10 ng/cannula) into the dorsal 
caudate/putamen or the lateral ventricles on male sexual behavior. 
Measures 
MF 
Ventricles 
Caudate 
IF 
Ventricles 
Caudate 
ATTRMPTS 
Ventricles 
Caudate 
CRAWLS 
Ventricles 
Caudate 
MISD IRBCTRIT- . 
Ventricles 
Caudate 
Baseline 
4.7 + 1.9 
5.0 + .2 
14.8 + 5.4 
11.5 + .6 
1.3 + 0.2 
1.7 + 0.2 
1.2 + 0.1 
1.6 + 0.2 
1.4 + 0 . 2 
1.4 + 0.2 
Substance P (10 ng) 
4.1 + 3.3 
4.4 + .3 
8.1 + 2.5 ** 
10.7 + .7 
1.7 + 0.1 
1.3 + 0.1 
1.3 + 0.1 
1.2 + 0.1 
1.1+0.2 
1.3+0.1 
All values are given as mean + S.E.M. See text for further details. 
** = P < 0.01, significantly different from caudate group. 
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Experiment 8: The Effects of Immunoneutralization of SP 
on Male Copulatory Behavior 
As previously ment ioned , both SP-immunoreactive cell bodies, fibers , and SP 
receptors have been reported in the MPOA-AH in rat brain (Simerly , Gorski , and 
Swanson, 1986; Mantyh , Hunt , and Maggio, 1984) . In addition , as revealed in 
experiment five , bilateral injections of SP into the MPOA-AH facilitated male 
copulatory behavior. Collectively, these findings strongly suggest that endogenous 
SP plays a role in the regulation of male sexual behavior at the level of t he 
MPOA-AH. On,~ way to test this possibility is by using receptor antagonists . F or 
example, if SP is acting via SP receptors , then blocking their activity should 
attenuate certain parameters of male copulatory behavior measured in the 
previous experiments. However, while receptor antagonists are commonly used to 
investigate the role of neuropeptides in a variety of behavioral experiments , with 
respect to SP, there is currently no specific antagonist for use in the CNS. To 
overcome this shortcoming, the technique of passive immunoneutralization of SP 
has been used . Indeed, in a recent study by Dornan , Malsbury, and Penney (1987) 
the role of endogenou~ SP in female sexual behavior was explored using a SP 
antiserum. In that s; udy , a purportedly potent SP antagonist failed to 
significantly decrease lordosis scores (a measure of female sexual receptivity) . A 
SP antiserum, on the other hand , significantly reduced lordosis scores. 
Accordingly, in experiment 8, bilateral injections of a SP antiserum into the 
MPOA-AH were done to explore the role of endogenous SP in male copulatory 
behavior. 
Methods and Results 
Animals and Surgery: 
Twenty adult male Sprague Dawley rats (350-405 grams) were used. Each 
animal received a pair of stereotaxically implanted guide cannulae aimed at the 
tvfPOA-AH. 
Behavioral Testing: 
As per general methods, with one exception. In an attempt to use males that 
were relatively sexually vigorous, all males were given four pre-operative tests. 
Intracerebral Injections: 
Animals were rando~-:-~y divided into two groups. One group (n = 10 per group) 
received bilateral iL.jec t ions of an undiluted SP antiserum (Immuno Nuclear lot # 
8605009) in a vohi:L'1 ·~ o~· 0.3 uljcannula. The other group received bilateral 
injections of normal rabtit Jerum· (same volume). 
Results 
Of the twenty animals, four did not satisfy criterion at . the first post-operative 
baseline test, and another could not be injected because the dummy cannula could 
not be removed. That left 15 animals with both cannulae located within the 
previously defined boundary of the MPOA-AH (see figure H)A and 19B). Data 
analysis was performed on these animals. As demonstrated in table 21, bilateral 
97(a) 
Bilateral cannula placements in 8 males that received injections of an undiluted 
substance P antiserum (0.3 microliters) into or near the MPOA-AH in experiment 
8. 
97. (b) 
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FIGURE IDB 
Bilateral cannula placements in 7 males that received injections of normal rabbit 
serum (NRS) in experiment 8. 
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injections of an undiluted SP antiserum (n = 8) significantly increased the 
number of intromissions to ejaculation compared to the normal rabbit serum 
injected controls (n = 7) (F = 5.2 , df, 1,14, P < 0.05). No other parameter was 
affe~ted (see tables 20 and 21), although, as can be seen from table 20, a trend 
toward longer latencies is evident in the antiserum group . 
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TABLE 20 
EXPERIMENT 8 : LATENCIES (in seconds) 
Effects of injections of normal rabbit serum (NRS) or anti-SP 
(0.3 ul/cannula) into the MPOA-AH on male sexual behavior. 
Measures 
ML 
Experimental 
Control 
IL 
Experimental 
Control 
EL 
Experimental 
Control 
ARL 
Experimental 
Control 
ICI 
Experimental 
Control 
PBI 
Experimental 
Control 
Experimental 
Control 
Baseline 
135.0 + 60 
42.8 + 28 
97.1 +50 
52.9 + 20 
491.4 + 120 
NRS 
104.3 + 62 
88.3 + 23 
500.9 + 110 540.5 + 125 
393.4 + 90 
448.3 + 132 457.8 + 110 
49.0 + 16 
39.0 + 11 
295.6 + 22 
314.6 + 35 
100 
100 
89.7 + 32 
377.1 + 36 
Anti-SP 
141.3 + 60 
119.7 + 65 
743.2 + 225 
624.3 + 200 
52.9 + 12 
369.3 + 32 
100 
100 
All values are given as mean + S.E.M. See text for further 
details. 
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TABLB 21 
RXPRRIMBNT 8 : FRRQURNC IRS 
Effects of intracerebral injections of normal rabbit serum (NRS) or 
anti-SP (0.3 ul/cannula) into the MPOA-AH on male sexual behavior. 
Measures 
MF 
Experimental 
Control 
IF 
Experimental 
Control 
ATTEMPTS 
Experimental 
Control 
CRAWLS 
Experimental 
Control 
MISDIRECTED 
Experimental 
Control 
Baseline 
9.7 + 6.0 
6.0 + 2.0 
11.0 + 4.0 
14.2 + 3.5 
1.2 + 0.1 
1.0 + 0.2 
1.0 + 0.4 
1.2 + 0.1 
2.4 + 0.4 
2.1 + 0.2 
NRS Anti-SP 
5.1 + 2.0 
3.5 + 1.3 
13.7 + 3.0 * 
7.4 + 1.6 
1.1 + 0.2 
1.3 + 0.2 
1.4 + 0.1 
1.3+0.1 
1.9 + 0.5 
4.6 + 1.2 
All values are given as mean + S.E.M. See text for further details. 
* = P < 0.05, significantly different from controls. 
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Experiment 9: The Effects of More Wide Spread 
Distribution of a SP Antiserum throughout 
the MPOA-AH on Male Copulatory Behavior 
In a recent study by Elliot , Nemeroff, and Kilts ( 1986) , they reported that 
different volumes of a SP antiserum solution (which contained the same amount 
of antiserum) injected into the nucleus accumbens produced differential effects on 
D-amphetamine-induced locomotor activity. In that study, bilateral injections of a 
SP antiserum in a volume of 0.5 ul had no effect on D-amphetamine-induced 
locomotor activity, whereas injections of 2 ul containing the same amount of 
antiserum significantly decreased the locomotor activity. They concluded that the 
effect of the larger volume probably reflected more wide spread diffusion of the 
antibody in the nucleus accumbens. Since the size of the nucleus accumbens is 
relatively similar to that of the MPOA-AH, it is not inconceivable that the lack of 
effect of the SP antiserum on most parameters of male copulatory behavior 
observed in Experiment 8 resulted from too small a volume of injection. 
Therefore, in experiment 9, the effects of a SP antiserum on male copulatory 
behavior were re-evaluated using a larger volume of antiserum and the identical 
procedure as that of experirr~e: ::1t 8. 
Materia! and Methods 
Animals and Surgery: 
A new group of 20 adult male Sprague Dawley rats (400-455 grams) was used. 
Each animal received a pair of stereotaxically implanted guide cannulae aimed at 
the NfPOA-AH. 
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Behavioral Testing and Intracerebral Injections: 
I den tical to that of Experiment 8. 
Results 
or the 20 animals that began the experiment, 17 had both cannulae located 
within the MPOA-AH. Two animals, however, failed to satisfy criterion at the 
post-operative baseline test. Data from the remaining 15 animals were analyzed. 
Figure 20A and 20B illustrate the rostral-caudal location within the MPOA-AH of 
the various bilateral cannulae implants in these animals. 
As can be seen from tables 22 and 23, intracerebral injection of 2 ul of an 
undiluted SP anti-serum (Immuno Nuclear, Lot # 8605009) (n = 8) impaired 
copulation compared to the normal rabbit serum (NRS) injected controls (n = 7). 
This was revealed by a significant increase in mount and intromission latencies (F 
11.9, df = 1,13, P < .01; F = 5.1, df = 1,13, P < 0.05, respectively), as well 
as the intercopulatory interval (F = 5.2, df = 1,13, P < 0.05). Not only did 
bilateral inj ecLions of the antiserum increase the interval to initiate copulation, 
but they markedly lengthened the ejaculation latency (F = 9.8, df, = 1,13, P < 
0.01). In contrast to experiment 8, however, bilateral injections of 2 ul of a SP 
antiserum had no effect on the number of intromissions necessary to achieve 
ejaculation. 
104(a) 
FIGURE 20A 
Bilateral cannula placements in 8 males that received injections of 2 microliters 
of an undiluted antiserum into or near the .MPOA-AH in experiment 9. 
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FIGURE 20B 
Cannula placements in 7 males that received injections of NRS into the tviPOA-
AH in experiment 9. 
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TABLB 22 
RXPRRIMENT 9 : LATRNCIBS (in seconds) 
Effects of injections of 2 ul of normal rabbit serum (NRS) or 
anti-SP into the MPOA-AH on male sexual behavior . 
Measures 
ML 
Experimental 
Control 
IL 
Experimental 
Control 
BL 
Experimental 
Control 
ABL 
Experimental 
Control 
ICI 
Experimental 
Control 
PBI 
Experimental 
Control 
Experimental 
Control 
Baseline 
61.5 + 19 
52.5 + 34 
39.5 + 13 
77.4 + 68 
533.6 + 155 
NRS 
42.5 + 18 
42.0 + 16 
430.6 + 161 405.5 + 76 
494.5 + 90 
352.7 + 97 362.6 + 55 
51.3 + 8 
42.5 + 12 
326.0 + 18 
286.0 + 35 
100 
100 
51.7 + 13 
377.1 + 36 
Anti-SP 
208.3 + 53 ** 
70.0 + 13 * 
852.6 + 191 ** 
782.9 + 200 * 
83.8 + 10 * 
332.7 +54 
87 
100 
All values are given as mean + S.E.M. See text for further details. 
* = P < 0.05, significantly different from controls. 
** = p < 0. 01 ' " " " " 
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TABLB 23 
EXPERIMENT 9 : FREQUENCIES 
Effects of injections of 2 ul of normal rabbit serum (NRS) 
or anti-SP into the MPOA-AH on male sexual behavior. 
Measures 
MF 
Experimental 
Control 
IF 
Experimental 
Control 
ATTEMPTS 
Experimental 
Control 
CRAWLS 
Experimental 
Control 
MISDIRBCTBD 
Experimental 
Control 
Baseline 
4.4 + 1.0 
4.8 + 0.9 
11.1 + 2.3 
9.5 + 1.1 
1.1 + 0.3 
1.7 + 0.2 
1.2 + 0.3 
1.4 + 0.1 
1.4 + 0.1 
1.4 + 0.3 
NRS Anti-SP 
5.0 + 1.0 
3.8 + 0.6 
9.8 + 1.8 
8.0 + 1.0 
1.1 + 0.1 
1.0 + 0.1 
1.1+0.1 
.85 + 0.1 
1.2 + 0.2 
1.2 + 0.1 
All values are given as mean + S.E.M. See text for further details. 
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Experiment 10: The Effects of Intracerebral Injections 
of SP on Male Sexual Behavior in Castrated Male Rats. 
As previously mentioned in the general introduction, the importance of 
testosterone for male copulatory behavior has been clearly demonstrated in a wide 
range of species. For example, in the rat, male copulatory behavior is eventually 
abolished following castration, and this effect is completely reversed following 
testosterone treatment. Recently, SP immunoreactivity within certain brain 
regions has been shown to be dependent on gonadal hormones in both female 
(Frankfurt et al., 1986; Tsuro, Hisano, Okamura, Tsukamoto, and Daikoku, 1984), 
and male rats (Dees and Kozlowski, 1984). Indeed, Dees and Kozlowski {1984) 
reported that castration decreased SP staining in the medial nucleus of the 
amygdala, an area which has been implicated in male sexual behavior. Based on 
the above studies, and the results of experiment 5, perhaps the gradual decline in 
male copulatory behavior following castration is a result of a decline of SP 
synthesis and hence a reduced availability at synapses in the .MPOA-AH. If so, 
bilateral SP injections into the .MPOA-AH might be able to reverse the decline in 
male sexual behavior that is normally observed following castration. 
Material and Methods 
Animals and Surgery: 
A new group of ten adult male Sprague Dawley rats ( 450-525 grams) was used. 
Each male was given two pre-operative screenings. Twenty-four hours following 
the second successful screening, each animal was anesthetized with Somnotol and 
bilaterally castrated using a ventral abdominal approach. Three weeks following 
surgery , all animals received a pair of stereotaxically implanted guide cannula 
aimed at the .MPOA-AH. 
10Q 
Behavioral Testing: 
Identical to experiment 5 
Intracerebral Injections: 
Four days following stereotaxic surgery animals received a baseline test. Five 
days following the baseline test, animals were injected bilaterally with 10 ng 
SP /.3 ul per cannula into the rvt:POA-AH. 
Results 
Of the ten animals that began the experiment, one died before completion of 
data acquisition. That left g animals which had both cannulae within the 
previously defined boundary of the rvt:POA-AH. Figure 21 illustrates these 
cannulae placements. 
As can be seen from table 24, 1 month following castration, sexual performance 
was greatly reduced compared to pre-castration levels. Subsequent bilateral 
injections of 10 ng of SP into the rvt:POA-AH failed to reinstate copulatory 
behavior in these males. 
llO(a) 
FIGURE 21 
Summarizes bilateral cannula placements in g males that received injections of 
10 ng of SP into or near the MPOA-AH in experiment 10. See figure 3 for a more 
detailed explanation. 
llO(b) 
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TABLR 24 
EXPERIMENT 10 
The effects of bilateral injections of SP into the MPOA-AH on sexual behavior 
in orchidectomized testosterone-deprived male rats. 
Number of animals 
displaying: 
MOUNTS 
INTRattiSSIONS 
EJACULATION 
Pre-castration 
(no treatment) 
9 I 9 
9 I 9 
9 I 9 
1 month post-
castration 
(no treatment) 
3 I 9 
1 I 9 
1 I 9 
SP (10 ng) 
1 I 9 
o I 9 
o I 9 
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Experiment 11: The Effect of Preoptic Injections 
of CCK-8 on Male Copulatory Behavior 
As previously mentioned (general introduction), CCK concentrations within 
some brain nuclei appear to be sexually differentiated, with males having higher 
concentrations than females. Also as in the case of SP, CCK concentrations in 
some brain nuclei seem to be dependent on gonadal hormones (A . .kesson and 
Micevych, 1986; Simerly and Swanson, 1987). 
Recently, CCK has been found to coexist and interact with the neurotransmitter 
dopamine (DA). For example, in a study by Kimura, Hashimoto and Kawakami 
( 1983), they reported that implants of CCK into the MPOA-AH facilitated the 
circadian rise of plasma LH in ovariectomized estrogen-treated female rats. These 
same authors have recently demonstrated that the CCK-induced facilitation of LH 
release is mediated by DA (Hashimoto and Kimura, 1986). In that study they 
reported that injections of CCK into the MPOA-AH enhanced the afternoon rise 
of LH in ferna.k- rats and : hat this enhancement could be completely blocked by 
pre-treatm.-· ~1t with a DA re<;eptor ~locker, pimozide. Collectively, the above 
studies suggest that DA and CCK have a functional interaction at the level of the 
MPOA-AH. This is of considerable interest since dopaminergic agonists have been 
shown to facilitate male sexual behavior when injected peripherally (Ahlenius and 
Larsson, 1984; Clark, Stefanick, Smith and Davidson, 1981), and more recently, 
when injected into the MPOA-AH (Hull et al., 1986). In light of this, it is possible 
that CCK may play a role in the neural mediation of male sexual behavior. 
Therefore, experiment 11 was designed to explored this possibility. Three different 
doses of CCK were bilaterally injected into the MPOA-AH and thC' effects of 
these injections on male sexual behavior examined. 
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Material and Methods 
Animals and Surgery: 
Forty adult male Sprague-Dawley rats (385-460 grams) were used. All animals 
received a pair of stereotaxically implanted guide cannulae aimed at the rvfPOA-
AH. 
Behavioral Testing: 
Identical to that of Experiment Five. 
Intracerebral Injections: 
CCK is a peptide consisting of 39 ammo acids. Immunochemical studies 
indicate, however, that in the brain, the octapeptide CCK-8 in sulphated form, 
and not the longer form (39 ammo acid sequence ) of CCK has the highest 
concentrations (Dcckray , 1g82). As a result, sulphated CCK-8 was used in the 
present experiment. Animals were divided into four groups (n = 10 each). Three 
groups received either 10 ng, 100 ng, or 200 ng of CCK-8 sulphated (Cambridge 
Research Biochemicals, Lot # P A 2048) in a volume of 0.3 ul per cannula into the 
~1POA-AH. Another group received saline (same volume). CCK-8 was dissolved in 
physiological saline. 
Results 
Of the forty animals, five died before completion of data acquisition, five did not 
satisfy criterion at the baseline test, two had both cannula located outside the 
MPOA-AH, and one was sick on the second test session, and as a result could not 
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be tested. That left 27 animals which had both cannulae within, immediately 
dorsal to, or immediately ventral to the ~OA-AH (see figure 22A and 22B). 
Only these animals were used for subsequent data analysis. 
Tables 25 and 26 demonstrate that bilateral injections of three doses of CCK-8 
(10 ng, n = 7; 100 ng, n = 6; 200 ng, n = 7) into the ~OA-AH had no 
significant effect on any of the behavioral parameters measured when compared 
to the saline injected control group (n = 7). For example, in contrast to SP 
which produced dramatic reductions in latencies, CCK did not seem to have any 
effect on mount, intromission or ejaculation latencies ( F = 1.8, df = 3,26, P > 
0.05; F = 0.86, df, 3,26, P > 0.05; F = 2.5, df, 3 ,26, P > 0.05, respectively). 
\Vith regard to frequencies, table 20 demonstrates that CCK injections had no 
appreciable effect or.. either mount or intromission frequencies (F = 1.8, df, 3,26, 
P > 0.05; F = 0.68, df, 3,26, P > 0.05 respectively) . Although no significant 
effects were observed following bilateral injections of CCK-8, there was a non-
significant trend for reduced latencies in the CCK group compared to the saline 
injected controls which was most noticeable with the higher doses of CCK-8 (see 
Table 25 ). This trend is also demonstrated in figures 23 and 24. IADL TS 
llS(a) 
FIGURE 22A 
Summarizes bilateral cannula _placements in 20 males that received injections of 
three different doses of CCK-8 into or near the .MPOA-AH in experiment 11. 
116(a) 
FIGURE 22B 
Bilateral cannula placements m 7 males that received saline injections into the 
iVIPOA-AH in experiment 11. 
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TABLE 25 
EXPERTIMBNT 11 : LATENCIES (in seconds) 
Effects of injections of saline or CCK-8 (sulphated) 
into the MPOA-AH on male sexual behavior. 
Measures (a) Baseline Saline 10 ng 
CCK-8 
100 ng 200 ng 
-------------------------------------------------------------------------------
ML 
Experimental 
Control 
IL 
Experimental 
Control 
BL 
Experimental 
Control 
ABL 
Experimental 
Control 
ICI 
Experimental 
Control 
PBI 
Experimental 
Control 
Experimental 
Control 
188.6 + 48 
141. 1 + 32 
183.7 + 48 
98.8 + 32 
190.6· + 35 
185.6 + 72 
194.0 + 32 
227.8 + 71 . 
973.2 + 146 826.0 + 235 
753.9 + 126 858.9 + 270 
789.2 + 129 598.0 + 210 
579.5 + 106 686.5 + 180 
75.3 + 11 
66.1 + 16 
304.4 + 21 
284.6 + 27 
100 
100 
90.3 + 20 
368.6 + 40 
100 
87.3 + 15 
370.7 + 21 
100 
145.7 + 40 129.8 + 13 
153.5 + 46 136.8 + 14 
604.6 + 85 618.5 + 59 
468.0 + 88 495.4 + 56 
53.5 + 8 68.8 + 10 
318.3 + 18 302.3 + 11 
100 100 
a) at baseline, all values for the experimental group are grand means. 
All values are given as mean + S.E.M. See text for further details. 
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TABLB 2 6 
EXPERIMENT 11 : FREQUENCIES 
Effects of injections of saline or CCK-8 (sulphated) 
into the MPOA-AH on male sexual behavior. 
Measures (a) 
MF 
Experimental 
Control 
IF 
Experimental 
Control 
ATTEMPTS 
Experimental 
Control 
CRAWLS 
Experimental 
Control 
MISDIRECTED 
Experimental 
Control 
-
Baseline 
4.7 + 1.3 
3.4 + .4 
13.0 + 2.0 
11.5 + 1.1 
1.1 + 0.1 
1.1 + 0.1 
1.3 + 0.1 
1.1 + 0.5 
1.8 + 0.3 
1.0 + 0.1 
Saline 10 ng 
3.5 + 1.0 
4.2 + 0.9 
9.5 + 1.1 
10.7 + 1.5 
1.2 + 0.2 
1.5 + 0.5 
1.2 + 0.4 
1.8 + 1.0 
1.7 + 0.2 
1.5 + 0.3 
CCK-8 
100 ng 200 ng 
3.1 + 0.8 4.0 + 1.0 
12.0 + 1.3 11.2 + .9 
1.0 + 0.1 1.2 + .2 
1.5 + 0.6 1.0 + 0.1 
1.0 + 0 1.7 + 0.3 
a) at baseline, all values for the experimental group are grand means. 
All values are given as mean + S.E.M. See text for further details. 
ll9(a) 
FIGURE 23 
Illustrates the proport ional change from a baseline test of ejaculation latencies in 
an imals that re~ eived three different doses of CCK-8, or saline into the MPOA-
AH in experiment 11. 
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FIGURE 24 
Illustrates the proportional change from a baseline test of intromission latencies 
in animals that received three different doses of CCK-8, or saline into the MPOA-
AH in experiment 11. 
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GENERAL DISCUSSION 
The results of the present series of experiments suggest that the SP innervation 
of the MPOA-AH, and perhaps other structures that lie in close proximity to 
ventricular circulation, are involved m the facilitation of masculine sexual 
behavior. This conclusion is partly based on changes that were observed in a 
variety of components of male sexual behavior subsequent to SP injections into 
the MPOA-AH (experiment 5) and the LV (experiment 6). In experiment 5, 
bilateral injections of three different doses of SP into the "MPOA-AH produced an 
immediate facilitation of male copulatory behavior compared to saline injected 
controls. The most marked effects of SP injections were on latencies, where all 
three doses significantly shortened the interval to initiate copulation, and 10 and 
100 ng, but not 200 ng, of SP also significantly reduced ejaculation latencies. It 
appeared that not only did SP injections into the "MPOA-AH decrease the 
latencies to initiate copulation, but they also increased the intensity of copulation. 
This was reflected by an overall decrease in the inter-copulatory interval (ICI) 
following bilateral injections of all three doses of SP into the MPOA- AH 
compared to the saline injected controls. Additionally, a reduction of the 
ejaculatory thres~old emerged following injections of 100 ng of SP into the 
MPOA-AH, as evidenc£:d by a significant decrease in the number of intromissions 
preceding ejaculation compared to the saline injected controls. Bilateral injections 
of SP into the MPOA-AH did not, however, facilitate male copulatory behavior in 
a linear dose-related fashion. 
The present study provides the first empirical evidence for a functional role of 
SP in the regulation of male sexual behavior. This peptide has previously been 
reported to have a sexually differentiated distribution within the CNS (Frankfurt 
et al., 1985; Malsbury and McKay, 1986). In addition, concentrations of SP 
within the CNS are dependent on circulating levels of gonadal hormones (Dees 
and Kozlowski, 1984). 
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In an attempt to ascertain whether the facilitation of male copulatory behavior 
observed in experiment 5 following bilateral injections of SP into the MPOA-AH 
was specific to the MPOA-AH, 10 ng of SP was bilaterally injected into the dorsal 
caudate/putamen (CP) in experiments 3 and 6. The results of these experiments 
demonstrate that SP synapses within the dorsal CP do not seem to be involved in 
the neural control of male copulatory behavior, as SP injections into this area had 
no appreciable effect on this behavior. 
Contrary to the results obtained m experiments 3 and 6, however, bilateral 
injections of 10 ng of SP into the lateral ventricles significantly decreased the 
number of intromissions necessary to achieve ejaculation, while at the same time 
lengthening mount latencies and the ICI. This suggests several interpretations. 
Firstly, in addition to the proposed importance of the SP innervation of the 
MPOA-AH in the expression of male sexual behavior, a site that lies in close 
proximity to the ventricular circulation may be involved in the mediation of a 
inhibitory effect of SP on male copulatory behavior. Secondly, a reduction in the 
number of intromissions preceding ejaculation was observed following 
intraventricular injections of SP (an effect produced by MPOA-AH injections of 
SP in expe::iment 5 ). Therefore, it is possible that SP injected into the MPOA-
AH in expe_·iment 5 may have diffused into the ventricular circulation, and 
produced some of its elfects by acting on the same brain site as that affected by 
LV injections. However, there were marked differences between the effects of LV 
and MPOA-AH injections of SP. Firstly, for the most part both mount and 
intromission latencies were longer in the LV group compared to the controls. 
Secondly, LV injections of 10 ng of SP significantly reduced the number of 
intromissions prior to ejaculation. This effect was not observed following MPOA-
AH injections of the same dose of SP. Thirdly, MPOA-AH injections significantly 
reduced the inter-copulatory interval (ICI) compared to the saline injected 
controls. This was not seen following LV injections of SP. In fact, LV injections of 
SP produced a significant increase in the ICI (see Table 12). Nonetheless, the fact 
that both LV and MPOA-AH injections significantly reduced intromission 
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frequencies still suggests that SP injected into the MPOA-AH may have leaked 
into the ventricular circulation and produced this effect by acting on the same 
structure(s) affected by LV injections. It is also possible that the effects of MPOA 
and LV injections on male copulatory behavior would have been more similar had 
a higher dose of SP been used in experiment 7. Indeed both the bed nucleus of 
the stria terminalis and the medial amygdala, two areas known to play a 
facilitatory role in male sexual behavior, have direct access to the ventricular 
circulation. 
Using the same logic, it is not inconceivable that SP injected into the lateral 
ventricles may have permeated into the MPOA-AH via the ventricular circulation, 
and produced its effect on intromission frequency by acting there. It is not known 
where in the brain the LV injections had their effects. Since bilateral injections of 
an identical dose of SP into the CP failed to alter any parameter of male sexual 
behavior, this suggests that SP injected into the lateral ventricles did not produce 
its effects on male sexual behavior in this area. Unfortunately, the role of SP on 
male sexual behavior was not examined following injections into other brain sites. 
Consequently, at this point, it is not known what structure(s) mediated the effects 
of the ventricular injections of SP. 
Therefore, baso2d on the results of experiments 5 through 10, it is suggested that 
the MPOA-AH, and possibly other structures with direct access to the ventricular 
circulation, may be important in the SP regulation of male sexual behavior. 
Bilateral Cannula Implants into the MPOA-AH 
Depress Levels of Male Sexual Behavior 
As is evident from the data in experiments 1 through 4, bilateral implants into 
the MPOA-AH were having a detrimenta.l effect on male copulatory behavior as a 
function of the post-operative test interval. An examination of the baseline level 
of sexual behavior in experiments 5 through 11, however, revealed that although 
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scores between testing sessions were relatively stable in MPOA-AH implanted 
animals using the new post-operative interval established m experiment 4, they 
were also relatively high. For example, in experiment 5, the mean baseline 
ejaculation latency in the control group was 810.9 compared to 623.0 in the 
caudate implanted animals in experiment 6, or 703.2 in the LV implanted animals 
in experiment 7. Therefore, it appeared that bilateral cannulae in the MPOA-AH 
produced higher baseline scores compared to non-MPOA-AH implanted animals. 
Additionally, comparisons of baseline sexual behavior of animals in experiments 5, 
8, and 9, all of which had bilateral cannulae in the MPOA-AH reveal differences 
in baseline scores (e.g., mean baseline ejaculation latencies of the experimental 
groups: experiment 5, 801.4; experiment 8, 491.4; experiment 9, 533.6). An 
examination of the distribution of cannulae implants in these animals did not 
reveal any marked differences. Shorter latencies in experiments 8 and 9 suggest 
that prio; sexual experience could have been a factor. For instance, in both 
experiments 8 and 9, animals had more preoperative ·screening tests in an attempt 
to make them more sexually vigorous. Accordingly, it appears that bilaterally 
implanted cannula in the MPOA-AH increased baseline copulatory behavior m 
less sexually vigorous males. Indeed, the ejaculation latencies of animals in 
experiment 11 (CCK-8 injections) compared to those of animals that underwent 
the same experimental proce~ui.·e (i.e., animals in experiment 5) appear similar 
(e.g. experimental group at baseline in experiment 5, 801.4; in experiment 11, 
973.2). 
As the above discussion has suggested, it appears that bilateral cannula implants 
into the MPOA-AH depress baseline copulatory behavior, and that this seems to 
interact with prior sexual experience. Accordingly, future studies are planned to 
investigate the effects of SP and CCK-8 injections on male copulatory behavior in 
unilaterally .MPOA-AH implanted animals. In addition, in future studies animals 
will be screened for baseline levels of sexual behavior, to ascertain whether 
SP /CCK-8 effects depend on them. 
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Does SP Influence Male Copulatory Behavior 
Via Arousal or Copulatory Mechanisms ? 
Beach (1956) proposed that, contrary to v1ewmg sexual behavior as a unitary 
construct, two separate mechanisms were involved in male reproductive behavior: 
a sexual arousal mechanism and a copulatory mechanism. He suggested that the 
arousal mechanism mediates the male's initiation of the copulatory sequence, as 
well as the resumption of copulation following ejaculation. The copulatory 
mechanism was assumed to maintain copulatory behavior by summating the 
excitation of each successive intromission until ejaculation occured. Since its 
original formulation the • two factor • theory of Beach has received considerable 
attention. As a result, its conceptual framework has been continually revised. 
Indeed, based on a factor analysis of normative data on sexual behavior in male 
rats, Sachs (1978) subsequently subdivided the copulatory mechanism into further 
dimensions, one of which he referred to as a • copulatory rate factor •. This 
factor contained three components: inter-intromission interval (which I have 
referred to here as the ICI), ejaculation latency, and the post-ejaculatory interval 
(PEl). The reason for inclusion of the PEl in the theoretical copulatory 
mechanism framework was to account for the relative independence of the PEl 
from mount and intromission latencies (two behavioral components associated 
with arousal). Sach's stated that rather than adopting a more parsimonious 
approach to the study of male sexual behavior, at least 4 conceptual mechanisms 
are need to completely account for male copulatory behavior. I agree with Sach's. 
Any theory that will ultimately elucidate the neurophysiolgical mechanisms 
underlying masculine sexual behavior must be comprised of multiple theoretical 
constructs. The multidimensional approach postulated by Sach's will undoubtedly 
facilitate our understanding of this complex behavior. 
Accordingly, individual parameters of the copulatory pattern that are associated 
with arousal mechanisms are mount and intromission latencies. Mount and 
intromission frequencies, along with ejaculation latencies, the ICI, and the PEl, 
are said to reflect copulatory mechanisms. 
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Data from experiment 5 support a role for SP being involved in both the arousal 
and copulatory mechanisms. For example, MPOA-AH injections of 10 ng and 100 
ng of SP dramatically reduced the interval to initiate copulation. This was 
reflected in a significant decrease in the intromission latencies, and a non-
significant trend for a reduction in mount latencies. Significant decreases in the 
inter- copulatory interval, intromission frequencies, and ejaculation latencies 
suggests that SP also facilitates the copulatory mechanism. Additionally, data 
obtained in experiment 9 revealed that bilateral injections of 2 ul of a SP 
antiserum significantly affected parameters of the copulatory sequence which are 
associated with both arousal and copulatory mechanisms (see Table 18). 
Collectively, the above results strongly suggest that endogenous SP plays an 
important role in regulating both the arousal and copulatory mechanisms in male 
copulatory behavior. 
One puzzling result from experiment 5, however, is SP's relative lack of effect 
on the PEl's. For instance, although MPOA-AH injections 10 and 200 ng of SP 
reduced PEl's, only the 100 ng dose produced a significant effect when compared 
to the saline injected controls. 
One explanation could b~ that the PEl is relatively resistant to change in 
Sprague-Dawley rats. For example, Bar(ield, Wilson, and McDonald (HJ75}, and 
Clark, Caggiula, McConnell and Antelman {1975} reported that, following 
midbrain lesions in sexual!y experienced male rats, dramatic reductions were seen 
in the PEl compared to sham operated controls. Furthermore, in a study by 
Walker, Gerall, and Kostrzewa {1981), they too reported significant reductions in 
the PEl following midbrain lesions in sexually experienced male rats compared to 
sham operated controls. The authors noted, however, that the reductions in the 
PEl's were considerably smaller in their study compared to those in the Barfield 
et al. and the Clark et al. studies. They suggested that a major factor responsible 
for the discrepancy among their studies could be strain differences. Barfield et al. 
used Long-Evans rats, while Walker et al. used Sprague-Dawley rats. Consistent 
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with this assertion, Foreman and Hall ( 1987) observed a significant facilitation of 
male copulatory behavior following peripheral administration of a selective 
dopaminergic agonist. Although 25, 100, and 250 ng/kg of L Y163502 significantly 
reduced mount, intromission, and ejaculation latencies, no effect was seen on the 
PEl. This is in contrast to evidence that suggests DA is critically involved in the 
regulation of the PEl (Mcintosh and Barfield, 1984b ). Again, Foreman and Hall 
used Sprague-Dawley rats. Indeed, the magnitude of the decrease of the PEl's in 
this study (experiment 5) following 10 and 100 ng of SP is almost identical to that 
seen in the Walker et al. study (18 % versus 17 % reduction, respectively). 
Accordingly, two possibilities are suggested concerning SP's involvement in 
determining the length of the PEL Firstly, SP has only a minor role in the 
mediation of the PEl. Secondly, an alternative explanation is that SP does play a 
role in determining the length of the PEl at the level of the MPOA-AH, but this 
role is relatively difficult to demonstrate in Sprague-Dawley rats. 
How Does SP Facilitate Male Rat Sexual Behavior ? 
SP and LHRH: 
As previously discussed, LI-ffiH administration has been shown to facilitate 
mating behavior in male rats (Dorsa and Smith, 1980; Dorsa, Smith, and 
Davidson, 1981; Moss, Dudley, Foreman, and McCann, 1975; Myers and Baum, 
1980). Moss et al. ( 1975) reported that in sexually experienced, gonad ally intact 
Sprague-Dawley male rats, subcutaneous injection of 500 ng of LHRH significantly 
decreased intromission and ejaculation latencies compared to saline injected 
controls. More recently, Myers and Baum (1980) have reported similar results. In 
that study, subcutaneous injections of LI-ffiH ( 1 ug) 1.5 hr prior to behavioral 
testing with a sexually receptive female significantly reduced ejaculation latencies 
in gonad ally intact males compared to saline injected controls. In that study, the 
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effects of LHRH on copulatory behavior were further explored in castrated 
testosterone- treated males. Interestingly, in this group, LHRH had no appreciable 
effect on copulatory behavior, other than producing a significant increase in the 
PEl (an effect not seen in the gonadally intact animals). In light of the preceding 
discussion , it should be pointed out that, in the Moss et al. ( 1975) study usmg 
Sprague-Dawley rats , LHRH had no effect on the PEL 
The above studies are interesting in view of the recent reports that indicate a 
role for SP in the regulation of luteinizing hormone (LH) release, presumably 
through release of LHRH in the median eminence. Vijayan and McCann {1979) 
reported that when SP was incubated with anterior pituitaries taken from 
ovariectomized rats, it failed to release LH. When it was injected into the 3rd 
ventricle, however, it significantly increased plasma LH levels. The authors 
concluded that this was presumably the result of a SP-induced release of LHRH in 
the median eminence. This central action of SP on LHRH was further supported 
in a recent study by Dees, Skelley and Kozlowski (1985). They reported that , in 
castrated male Sprague-Dawley rats, ventricular injection of a SP antiserum 
resulted in a signi7icant decrease in serum LH levels compared to the normal 
rabbit serum (NRS) injected control group. These results provide further (albeit 
indirect) support for the hypothesis that SP acts centrally to stimulate LH 
secretion via LHRH. 
Perhaps SP releases LHRH from LHRH-containing neurons in the MPOA-AH. If 
this were the case, it is possible that the SP- induced facilitation of male 
copulatory behavior observed in experiment 5 could have been mediated via 
LHRH release within the MPOA-AH. Indeed, immunocytochemical studies have 
revealed numerous LHRH cell bodies and fibers located within the .MPOA-AH 
(Bennet-Clarke and Joseph, 1982; Ibata, Watanabe, Kinoshita, Kubo, and Sano, 
1979; Witkin, Paden, and Silverman, 1982). Moreover, m a recent 
immunohistochemical study by Hoffman (1985), light-microscopic examination of 
immunostained SP fibers revealed a close apposition of SP fibers to LHRH cell 
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bodies in the preoptic area of male mice, suggestive of synaptic associations with 
these neurons. More recently, Tsuruo, Hisana, Nakanishi, Katoh, and Daikoku 
( 1987) report that electron microscopic examination of SP- immunoreactive nerve 
terminals in the preoptic area of male rats revealed SP synaptic contacts with 
LHRH neurons (unpublished data). In light of these recent data, it is possible that 
bilateral injections of SP into the MPOA-AH result in a release of LHRH and a 
subsequent enhancement of male copulatory behavior. 
SP and Dopamine 
A number of • in vitro • and • m vivo • studies have revealed that SP 
enhances the release of dopamine m the CNS (Garcia-Sevilla, Magnusson, 
Carlsson, and Folkers, 1983; Michelot, Leviel, Giorguieff-Chesselet, Cheramy, and 
Glowinski, 1979; Petit and Glowinski, 1986; Silbergeld and Walters, 1979). For 
example, in a study by Petit and Glowinski ( 1986), striatal slices taken from adult 
male Sprague-Dawley rats were continuously superfused with tritiated tyrosine so 
that the release of r.ewly synthesized radioactively labeled dopamine could be 
estimated. Forty minutes after beginning the superfusion, SP was added to the 
superfusion medium and the amount of newly synthesized DA released was 
compared to the amount released before the addition of SP. They reported that 
SP applied to striatal slices in this manner markedly increased the release of 
newly synthesized dopamine. Other studies have shown that SP injected into the 
substantia nigra causes dopaminergic dependent turning, and stereotyped 
behavior in rats (Eison, Eison and Iversen, 1982; James and Starr, 1979). 
Collectively, these studies strongly suggest an interaction between DA and SP 
neurons in the CNS. As previously mentioned, dopamine has been shown to 
facilitate male copulatory behavior in both gonadally intact and castrated male 
rats. Studies have demonstrated a facilitatory effect on male copulatory behavior 
following peripheral administration of DA agonists, which can be completely 
abolished by pre-treatment with DA receptor blockers. Moreover, the similarity 
between the facilitatory effects following SP injections in experiment 5 and those 
130 
reported following DA enhancement is particularly interesting m view of the 
above mentioned interaction between SP and DA. For example, in the Foreman 
and Hall (1987) study, following subcutaneous administration of a dopamine 
agonist, reductions in ejaculation latencies were of a similar magnitude to those 
observed in experiment 5 ( 46 % versus 53 % respectively). 
This evidence is only suggestive. Nonetheless, in view of the studies that 
support a DA/SP functional interaction in the CNS, and of the similarity of the 
effects of DA agonists and SP on male copulatory behavior, perhaps exogenous SP 
injected into the MPOA-AH is facilitating male copulatory behavior via DA 
release in the MPOA-AH. This would suggest that release of endogenous SP in the 
MPOA-AH promotes the release of DA. Consistent with this hypothesis, 
endogenous SP has been recently shown to modulate the release of DA in the 
nucleus accumbens (Elliott et al., 1986). In that study, injections of a SP 
antiserum into the nucleus accumbens induced a significant increase in DA 
concentrations in i:l.a-.: ,;.:ea. The authors concluded that this reflected the 
intracellular accumulation and metabolism (as they also measured DOPAC) of DA 
which had not undergone a release-reuptake cycle, and they suggested that, at the 
level of the nucleus accumbens, SP exerts a tonic facilitatory effect on DA release. 
The above hypothesis is further strengthened by results which demonstrate that 
simultaneous injections of S? and DA into the nucleus accumbens enhance DA-
induced increases in motor activity. Therefore, in view of the above studies, and 
of the recent report by Hull et al. (1986), which demonstrated a functional role of 
DA in male copulatory behavior at the level of the MPOA-AH, it is not 
inconceivable that the SP-induced facilitation of male copulatory behavior was 
mediated by increased DA release in the MPOA-AH. 
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Is the Release of Endogenous SP Within the MPOA-AH 
Important for Male Rat Copulatory Behavior ? 
rvfPOA-AH injections of a SP antiserum were used to explore this possibility in 
experiments 8 and 9. In experiment 8, injections of an undiluted SP antiserum 
into the rvfPOA-AH failed to have a dramatic effect on male copulatory behavior. 
The only parameter that was affected was intromission frequency , where 
injections of 0.3 ul of the SP antiserum significantly increased the number of 
intromissions necessary to achieve ejaculation compared to the normal rabbit 
serum (NRS) injected controls. In experiment 9, however, bilateral injections of a 
larger volume (2 ul) of an undiluted SP antiserum into the :MPOA-AH produced a 
dramatic impairment of male copulatory behavior. For instance, compared to the 
NRS injected control group, injections of 2 ul of the antiserum in sexually 
experienced male rats significantly lengthened mount, intromission, and 
ejaculation latencies (see Table 22). It is possible that the failure of the SP 
antiserum to alter the copulatory behavior in experiment 8, yet have a dramatic 
effect in experiment 9, is related to the presumably more wide spread distribution 
of the larger volume of antise:um throughout the rvfPOA-AH in experiment 9. 
Indeed, the distribution of SP fibers and receptors within the rvfPOA- AH is 
widespread (Ljungdahl, Hokfelt, Nilsson, 1978; Mantyh, Hunt, and Maggio, 1984; 
Quirion, Shults, Moody, Pert, Chase, O'Donohue, 1983; Simerly, Gorski, Swanson, 
1986; Takatsuki, Sakanaka, Takagi, Tohyama, Shiotani, 1983). As a result, it may 
be difficult to interfere with copulatory behavior with a small volume of SP 
antiserum. Similarly, small lesions within the MPOA-AH are relatively ineffective 
in disrupting male copulatory behavior as compared to large lesions (Arendash 
and Gorski, 1983; Christensen, Nance, Gorski, 1977; Heimer and Larsson , 
1966/67). Also, Szechtman, Caggiula, and Wulkan (1978) reported that knife cuts 
which severed at least 50 % of the medial-lateral connections of the MPOA-AH 
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had the greatest probability of disrupting male copulatory behavior in sexually 
experienced male rats. Thus, the data from experiment 9 suggest that the release 
of endogenous SP in the 'MPOA-AH is important in the regulation of male 
copulatory behavior. 
How do SP Neurons Participate in the Neural 
Circuitry Mediating Male Copulatory Behavior ? 
It is widely held that, in addition to the 'MPOA-AH, the medial amygdala 
(rnAMY), and the bed nucleus of the stria terminalis (BnST) are critically 
important for the expression of male rat sexual behavior (Larsson, 1979). In rats, 
lesions of the ~fY result in severe impairment of copulatory behavior, 
characterized by a decrease in the number of animals displaying ejaculation 
during mating tests. In addition, in some animals when ejaculation does occur, 
marked prolongation of ejaculation latencies, as well as dramatic increases in the 
number of intromissions preceding ejaculation have been noted (Beck, Fonberg, 
and Korczynski, 1982; Harris and Sachs, 1975). Conversely, testosterone or 
dihydrotestosterone implants into the rnAMY have been shown to facilitate male 
copulatory behavior in both rats and hamsters (Baum, Tobet, Starr, and 
Bradshaw, 1982; Bergondy, Powers, Matochik, Justice, 1984). Lesions of the BnST 
impair male copulatory behavior in a similar fashion (Bergondy, and Powers, 
1986; Emery and Sachs, 1976; Valcourt and Sachs, 1978). 
The 'MPOA-AH has afferent and efferent connections with the rnAMY via the 
stria terminalis, and via short axonal reciprocal connections, with the BnST (Berk 
and Finkelstein, 1981; Conrad and Pfaff, 1976; Simmerly and Swanson, 1986; 
Swanson, 1976; Tanemichi and Murata, 1985). Not surprisingly then, the rnAMY--
BnST--'MPOA-AH circuit (amygdala-preoptic circuit) has been proposed to be 
intimately involved in the neural regulation of male copulatory behavior (see Hart 
and Leedy, 1985 for a review). The identity of the neurotransmitter /peptide that 
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regulates copulatory behavior with'n the amygdalo-preoptic circuit in the male 
rat, however, has not been established. Immunocytochemical studies report large 
numbers of SP cell bodies and fibers in the MPOA-AH, BnST and in the mAMY 
(Cuello, Priestley, and Paxinos, 1985; Emson, Jessel, Paxinos, and Cuello, 1978; 
Ljungdahl, Hokfelt, and N:lsson, 1978; Sakanka, Shioskaka, Takatsuki, Inagaki, 
Takagi, Senba, Kawai, Ma.Buzaki, and Tohyama, 1981; Simmerly, Gorski, and 
Swanson, 1986; Takatsuki, Sakanaka, Takagi, Tohyama, and Shiotani, 1983; 
Woodhams, Roberts, Polak, and Crow, 1983). Additionally, immunohistochemical 
studies have revealed that the stria terminalis, which connects the above 
structures, contains large numbers of SP-immunoreactive fibers (Ben- Ari, 
LaSalle, and Kanazawa, 1977; Sakanaka et al., 1981). Castration has been shown 
to significantly reduce the number and intensity of immunostained SP fibers 
within the mAMY (Dees and Kozlowski, 1984). As previously mentioned, our 
laboratory has recently reported a sex difference in the pattern of SP- like 
immunoreactivity within the most caudal part of the medial BnST, with males 
exhibiting a densely stained capsule surrounding a less dense core, which was 
barely detectable in female rats. 
Based on the above discuss~-=>n, it appears that most components of male sexual 
behavior depend on neural impulses within the amygdalo-preoptic circuit. 
Additionally, the expression of masculine sexual behavior within this circuit is 
dependent on circulating levels of androgens. In the absence of testosterone, the 
integrity of the above system is insufficient to maintain copulatory behavior. This 
has rather interesting implications in view of the previously mentioned 
immunohistochemical studies of SP within this circuit. In light of these reports, it 
is possible that SP neurotransmission within this system plays a fundamental role 
in the expression of copulation in the male rat. Since the mAMY has been 
implicated in sensorimotor integration (Turner, 1981), perhaps olfactory cues from 
a sexually receptive female increase the activity of SP containing neurons in the 
mAMY (the mAMY receives direct innervation from the accessory olfactory bulb, 
which is itself a recipient of peripheral input from the vomeronasal organ). 
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In support of the above, neuronal activity in the hypothalamus has been shown 
to be more responsive to peripheral stimulation following treatment with steroid 
hormones (Alcaraz,Guzman-Flores, Salas,_ and Beyer, 1969; Pfaff and McEwen, 
1983). Also, Yagi (1967) found neurons in the medial anterior hypothalamus 
whose activity was raised within minutes following systemic injection of estradiol. 
Interestingly, mating has been shown to lead to an increase in testosterone levels 
in the male rat (Graham and Desjardin, 1980), and the mAMY has been shown to 
contain estrogen and androgen-binding neurons (Pfaff, and Keiner, 1973). 
Moreover, recently, SP has been reported to be located in hypothalamic neurons 
which bind estrogen (A.kesson, Coquelin, and Micevych 1986). This is particularly 
compelling in view of the fact that testosterone is converted to estrogen by 
aromatization (Whalen, Yahr, and Luttge, 1985). Indeed, the mAMY, like the 
rvf.POA-AH, and BnST, has been reported to contain high levels of aromatase 
activity which itself appears to be regulated by circulating levels of steroids 
(Roselli, Horton and Resko, 1985). Therefore, it is not inconceivable that 
androgen or estrogen concentrating cells within the mAMY also contain SP. 
Although only suggestive from the above, it is possible that increased levels of 
testosterone may enter SP neurons in the mAMY and as a result stimulate SP 
synthesis. This increased synthesis, along with a heightened sensitivity to 
peripheral stimulation (i.e. olfactory cues, tactile stimulation from the female, 
etc.) may enhance SP neuronal responses to excitatory afferents from the 
olfactory system. Consequently, increased SP synthesis and transport within 
androphilic or estrophilic neurons in the medial amygdala could lead to increased 
SP being transported down axons through the ST pathway. This increased SP 
transport would undoubtedly increase SP postsynaptic activity in the BnST via 
the stria terminalis SP pathway. The resultant convergence of SP innervation 
from the medial BnST and from mAMY to the rvf.POA-AH may be of 
fundamental importance in the neural regulation of male sexual behavior. Indeed, 
iontophoretically applied SP has been shown to excite MPOA-AH neurons in the 
rat (Mayer and Macleod, 1979). Moreover, in the Mayer and Macleod study they 
further reported that electrical stimulation of the BnST evoked excitations in 60 
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% of MPOA-AH neurons. More interestingly, of those neurons excited by BnST 
stimulation, 72 % were excited by SP. 
Figure 25 is a schematic representation of the proposed • SP- Sexually-
Differentiated Amygdalo-Preoptic Circuit (SP-SDC) • that is postulated to be 
intimately involved in the neural regulation of male copulatory behavior. 
Is Testosterone Required for the SP 
Activation of Male Copulatory Behavior ? 
The results of experiment 10 demonstrate that increased SP activity within the 
MPOA-AH is incapable of inducing copulatory behavior in castrated rats deprived 
of testosterone. Bilateral injections of 10 ng of SP into the MPOA-AH failed to 
increase the number of animals displaying mounting,· intromission and ejaculation 
during a 30 minute mating test with a sexually receptive female. There are a 
number of explanations that could account for this. Firstly, it is possible that a 
certain degree of circulating testosterone is necessary in order for SP to facilitate 
copulatoq behavior. Indeed , minimal levels of circulating hormones are required 
for intra:::er~bral injections to facilitate female sexual behavior (Dornan et al., 
1987; Saku~-aa and Pfaff, 1983; Harlan et al., 1982). Along the same lines, perhaps 
a particular degree of baseline sexual behavior is needed before localized 
intracerebral injections of SP can facilitate copulatory behavior. Secondly, in the 
studies that have revealed a facilitation of male copulatory behavior in the 
absence of testosterone following enhancement of DA activity, none have used 
intracerebral injections. Since peripheral administration of pharmacologically 
active compounds activates multiple brain, as well as peripheral sites, it is possible 
that increased SP activity within the MPOA-AH alone was insufficient to 
reinstate copulatory behavior in the castrated, testosterone- deprived males. The 
results of experiment 10, however, do not support the proposed SP /DA 
interaction in male sexual behavior, as DA has been shown to facilitate male 
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FIGURE 25 
Illustration of the SP-Sexually Differentiated Amygdala-Preoptic Circuit (SP-
SDC) that is postulated to play a critical role in the neural regulation of male 
sexual behavior (see text for details). Abbreviations: AOB, accessory olfactory 
bulb; BnST, bed nucleus stria terminalis; LOT, lateral olfactory tract; mAMY, 
medial nucleus of the amygdala; MOB, main olfactory bulb; MPOA-AI-I, medial 
preoptic area-anterior hypothalamic continuum; ST, stria terminalis; VMO, 
vomeronasal organ. Question marks indicate the possibility of androgen/ estrogen 
binding cells which also contain substance P (SP). 
Chemosensory 
Input: 
SP 
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copulatory behavior m the absence of testosterone. The present data, however, 
are congruous with a postulated interaction of SP and LlffiH, as peripheral 
administration of LlffiH failed to reinstate copulatory behavior in castrated male 
rats (Moss et al., 1g75 ). 
How Does Increased SP Activity in the MPOA-AH 
Mediate Male Sexual Behavior ? 
Although the below is highly speculative, a recent report by Blumberg, Mennella 
and Moltz (lg87) may shed some light on how increased SP activity in the 
MPOA-AH may regulate male sexual behavior. Based on the importance of the 
MPOA-AH in the expression of male sexual behavior, and on the involvement of 
the MPOA-AH in the regulation of body temperature, Blumberg et al. explored 
the possibility of a distinctive temperature profile during copulation in the male 
rat. They examined this possibility by monitoring both MPOA-AH and deep body 
temperature in sexually experienced male rats following the introduction of a 
sexually receptive female through sexual exhaustion. They found that the 
temperature of the r-.1POA-AH began to rise within one minute after introduction 
of the female, and continued until the first ejaculation, whereupon the MPOA-AH 
temperature began to drop. This specific pattern was evident throughout the 
testing period. Moreover, following MPOA-AH cooling (which lasted for about 4 
minutes) the .MPOA-AH began to heat up again. Interestingly, this increase was 
apparent just prior to the first mount subsequent to the first ejaculation. Changes 
in body temperature were not as uniform as MPOA-AH changes. The rvfPOA- AH 
temperature profile observed during copulation, however, did not seem to be 
secondary to obvious changes in motor activity that occur during the copulatory 
sequence. This was tested by running animals on a motor driven exercise wheel 
and monitoring MPOA-AH temperature. Although the running was sufficiently 
strenuous to induce physical exhaustion in the animals, the mean rv,IPOA-AH 
temperature increase following exercise tended to be less than that observed 
during copulation. 
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Peripherally, SP is one of the most potent vasodilators known (Chahl and 
Walker, 1981; Pernow, 1983). In humans, intravenous injection of 1 ng of SP 
produces an immediate increase in blood flow in the skin and muscle of the 
forearm (Eklund, Jogestrand, and Pernow, 1977). In a recent study by Dib (1987) 
using rats, he reported that following intrathecal injection of SP , a significant 
increase in the amount of time spent bar pressing to obtain a cool wind was 
observed compared to saline injected controls. Although SP did not have any 
effect on body temperature, it did stimulate thermoregulatory behavior, which for 
the rat is one of the major mechanisms of heat dissipation. In fact, Dib ( 1987) 
reported that the bar pressing induced by SP in that experiment resembled bar 
pressing following hypothalamic heating. Moreover, warming of the preoptic area 
has been shown to increase grooming in rats (Roberts and Mooney, 1974), and 
grooming has been previously reported to be stimulated by increased SP activity 
in the CNS (Kelly and Iversen, 1978; 1979). Accordingly, SP may shorten 
initiation of copulation, as well as the ejaculation latencies, by increasing MPOA-
AR temperature. In other words, in view of the Blumberg et al. study, where they 
reported that the increase in MPOA-AH temperature preceded the first mount 
following ejaculation, perhaps exogenous SP injected into the MPOA-AR leads to 
an acute increase in an MPOA-AR generated temperature signal either directly 
via an i r:. >-·raction with neuronal receptors, or indirectly via increases in MPOA-
AH blood flow. Consistent with the increased blood flow hypothesis, Klugman, 
Lembeck, Markowitz, Mitchell and Rosendorff (1980) report that injections of SP 
(50 or 500 ng) directly into the hypothalamus in conscious anesthetized rabbits 
produced a significant increase in hypothalamic blood flow compared to a control 
group which received injections of a mixture of the amino acids contained in SP. 
Consequently, the increase in MPOA-AH temperature following exogenous SP 
might act as a cue to the animals, and thereby shorten the latency to initiate 
copulatory behavior. Indeed, preoptic area neurons have been shown to increase 
their firing rate following increases in temperature (Nutik, 1973). Similarly, the 
marked decrease in ejaculation latencies observed in experiment 5, could be 
explained by the increase in MPOA-AH temperature if this does, as Blumberg et 
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al. (1987) suggest, play a role in regulation of ejaculation latencies. One way to 
test whether SP could alter PEl's, would be to inject SP into the tvfPOA-AH 
immediately after ejacuhtion. For example, if the subsequent increase in .MPOA-
AH temperature determines the timing of the next copulatory event, then SP 
should theoretically shci·ten the PEL Future studies investigating the 
thermoregulatory role of SP in the rvfPOA-AH are needed before any firm 
conclusions can be drawn. 
Is CCK Involved in the Neural Regulation 
of Male Sexual Behavior? 
Although it was believed that the CCK-8 innervation of the tvfPOA-AH might 
play a role in the mediation of male copulatory behavior, in this study, bilateral 
injections of three different doses of CCK-8 into the tvfPOA-AH failed to 
significantly affect any parameter of male copulatory behavior. Numerous CCK-8 
immunoreactive cell bodies and fibers are located in the tvfPOA-AH (Micevych, 
Park, AkessoL , and Elde, 1987; Simerly, Gorski, and Swanson, 1986), and CCK- 8 
has been sh•JWn to be a potent excitant in hypothalamic slice preparations (Pan, 
Kow, and Pfaff, 1986). Moreover, like SP, CCK concentrations within the CNS 
have been shown to be dependent on gonadal hormones (Frankfurt, Siegel, Sim, 
and \Vuttke, 1986). Indeed, in a recent study by Simerly and Swanson ( 1987), 
they reported that 2 weeks following castration m male rats CCK-8-
immunoreactivity was virtually eliminated in the mAMY, BnST, and MPOA-AH. 
Furthermore, recent reports suggest that concentrations of CCK-like 
immunoreactivity m the tvfPOA-AH are higher m male than female rats 
(Frankfurt, Siegel, Sim, _ \Vuttke, 1986; Micevych et al. 1987). Since CCK-8, like 
SP, is found in the amygdalo- preoptic cell groups previously implicated in sexual 
behavior, and since its concentrations are dependent on circulating levels of 
gonadal hormones~ I hypothesized that CCK-8 would be involved in the neural 
regulation of male sexual behavior. Nevertheless, the present study failed to 
reveal any effect of tvfPOA-AH injections of CCK-8. 
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There are number of possible explanations for this. Firstly, it is possible that 
CCK regulates male copulatory behavior in another brain site. Although CCK-8 
did not have any effect on male copulatory behavior following injections into the 
NIPOA- AH, it may be that different results would have been obtained if CCK-8 
would have been injected into another area of the brain which has been 
implicated in male sexual behavior {i.e. BnST or rnAMY). Secondly, although 
there is some suggestion of a potentiation of DA release by CCK-8 (Crawley, 
Hommer, and Skirboll, 1985 ), other data from behavioral as well as 
electrophysiological studies suggest that DA and CCK-8 may be functionally 
opposed to each other (Lane, Blaha, and Phillips, 1986; Moroji, Watanabe, Aoki, 
and Itoh, 1982; Wang and Hu, 1986). Indeed, in a study by Wang and Hu (1986), 
they report that CCK-8 markedly reduced the inhibitory effects of DA, following 
simultaneous microiontophoretic application of CCK-8 and DA on spontaneously 
active or glutamate-activated neurons in the nucleus accumbens. At no time did 
they detect any evidence of a potentiation. Consistent with the above are the 
recent findings reported by Lane, Blaha, and Phillips (1986). They report that i.v. 
administration of CCK-8 produced a dose-related inhibition of DA release in the 
nucleus accumbens. Moreover, hyperactivity which follows apomorphine injections 
into the nucleus accumbens can be completely abolished by pretreatment of the 
nucleus accumbens with CCK-8 (Van Ree, Gaffori, and \Vied, 1983). This effect 
has been recently shown to be mediated by a CCK-8-induced release of 
endogenous opioids (Kiraly and Van Ree, 1987). Collectively, these studies suggest 
that CCK-8 may act (in the nucleus accumbens) as a DA-antagonist and that this 
action is partly mediated by endogenous opioids. Accordingly, a preliminary 
interpretation would be that the lack of effect of CCK-8 on male copulatory 
behavior is due to its unique effects on both DA and endogenous opioids. In fact, 
if CCK-8 acts in the same way in the NIPOA-AH, it would be expected to inhibit 
male copulatory behavior. Thirdly, and certainly more relevant to this study, is 
the recent report by Babcock, Bloom, Bloch, and Micevych (1986). In that study, 
peripheral injections of CCK-8 in gonadally intact or castrated male rats had no 
effect on male copulatory behavior. 
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Alternatively, the baseline sexual behavior of the males might explain the lack 
of effect of CCK-8 m the present study. For example, Bloch, Babcock, Gorski, 
and Micevych (1987) reported differential effects of CCK-8 on female sexual 
behavior (facilitatory and inhibitory) which was dependent on the initial degree of 
sexual receptivity. Intraperitoneal administration of CCK-8 in ovariectomized 
estrogen treated female rats facilitated lordosis only in animals displaying a low 
level of sexual receptivity. It is possible that bilateral injections of CCK-8 into the 
MPOA-AH might have had an affect on copulatory behavior in males that were 
sexually inexperienced or that displayed relatively poor baseline scores. Although 
again highly speculative, such a hypothesis is not inconceivable in light of the 
recent reports of the differential effects of opiates on male copulatory behavior 
which seem to depend on the rat's sexual experience, or baseline copulatory 
behavior prior to treatment (Gessa et al., 1979; Leiblich et al., 1985; Mcintosh et 
al., 1980). 
Finally, it IS possible that MPOA-AH neurons involved in male copulatory 
behavior are not as sensitive to CCK-8 as they are to SP, and as a result may 
demonstrate a different dose- response profile to CCK-8. For example, perhaps an 
effect on male copulatory behavior would have been observed in experiment 11 if 
higher doses of CCK-8 had been used. Indeed there was a non-significant trend of 
reduced latencies following higl:.er doses of CCK-8. Future studies, employing 
higher doses of CCK-8 will determine whether the above statement is correct. 
Conclusion 
In conclusion, this thesis supports the idea that the SP neurons which innervate 
the MPOA-AH form part of the neuronal circuitry which regulates male rat 
copulatory behavior. It is postulated that among other pathways that have been 
shown to be involved in male sexual behavior, the SP-SDC (figure 25) forms part 
of the neural circuitry which is critically important in the regulation of male 
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sexual behavior. Furthermore, as a result of the relative lack of effect of both SP 
and LHRH on the PEl, and the data which reveal SP fibers in close apposition to 
LHRH neurons in the ~1POA-AH, it is postulated that increased SP activity, 
perhaps along with a SP-induced increase in LHRH activity within this circuit, is 
of crucial importance for maintaining copulatory behavior in the male rat. 
Further experiments are required to elucidate the mechanisms by which SP and 
LHRH mediate male sexual behavior at the level of the MPOA-AH. Additionally , 
the functional role that SP and/or LHRH play(s) in male copulatory behavior at 
the level of the mAMY and the BnST requires exploration before the importance 
of the SP-SDC in male copulatory behavior is clearly established. 
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APPENDIX 
ANALYSIS OF COVARIANCE TABLES 
SOURCE 
161 
ORDER EFFECT 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 55942.4 1 55942.4 14.3* 
EXPLAINED 220913 . 5 2 110456.7 28.2 
RESIDUAL 19538.2 5 3907.6 
TOTAL 240451.8 7 34350.2 
SOURCE 
162 
ORDER EFFECT 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 143334.0 1 143334.0 6.5* 
EXPLAINED 232899 . 1 2 116449.5 5. 3 
RESIDUAL 109017.7 5 21803.5 
TOTAL 341916.8 7 48845.2 
SOURCE 
163 
ORDER EFFECT 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 88958.5 1 88958.5 7.5* 
EXPLAINED 214171.5 2 71247.0 9.0 
RESIDUAL 49495.5 5 9899.1 
TOTAL 191990.0 7 27427.1 
SOURCE 
164 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 93145.8 2 46572.6 0 . 3 
EXPLAINED 95954.2 3 31984.7 0.2 
RESIDUAL 2097498.5 15 139833.2. 
TOTAL 2193452.6 18 121858.4 
SOURCE 
165 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 80244.8 2 40122.4 0.6 
EXPLAINED 272556.9 3 90852.3 0.9 
RESIDUAL 1452749.6 15 96849.9 
TOTAL 1725306.5 18 95850.4 
SOURCE 
166 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 358739.6 2 179369.8 0.4 
EXPLAINED 365903.5 3 121967.8 0 . 7 
RESIDUAL 3526511.5 15 235100.7 
TOTAL 3892415 . 1 18 216245.3 
SOURCE 
167 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 238155.9 2 119077.6 0.8 
EXPLAINED 241401.1 3 80467.0 0.4 
RESIDUAL 2048518.5 15 136567.9 
TOTAL 2289919.6 18 127217.7 
SOURCE 
168 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEl) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEl 219851.9 2 109777.6 0.4 
EXPLAINED 41401.1 3 0467.0 0.1 
RESIDUAL 2048518.5 15 136567.9 
TOTAL 2289919.6 18 127217.7 
SOURCE 
169 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 2821.6 2 1410.8 1.7 
EXPLAINED 8996.2 3 2998.7 3.7 
RESIDUAL 11987.8 15 799.1 
TOTAL 20984.0 18 1165.7 
SOURCE 
170 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 3.5 2 1.7 0.9 
EXPLAINED 18.6 3 6.1 0.9 
RESIDUAL 522.0 15 34.8 
TOTAL 540.4 18 30.0 
SOURCE 
171 
EXPERIMENT 1 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 89.7 2 44.8 0.5 
EXPLAINED 317.4 3 105.8 0.2 
RESIDUAL 966.5 15 64.4 
TOTAL 1284.0 18 71.3 
SOURCE 
172 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 186414.9 1 186414.9 5.6 
EXPLAINED 189838.3 2 94917.1 2.8 
RESIDUAL 230758.0 7 32965.4 
TOTAL 420596.4 9 46732.9 
SOURCE 
173 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 163779.3 1 163779.3 5.7 * 
EXPLAINED 206394.5 2 103197.2 3.6 
RESIDUAL 200020.0 7 28574.2 
TOTAL 406414.5 9 45157.2 
SOURCE 
174 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 844866.0 1 844866.0 11.0 * 
EXPLAINED 1523841.9 2 761920 . 9 9.9 * 
RESIDUAL 537598.1 7 76799.7 
TOTAL 2061440.1 9 229048.9 
SOURCE 
175 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 318780.8 1 318780.8 2. 3 
EXPLAINED 661114.6 2 330557.2 0.1 
RESIDUAL 1013536.3 9 144790.9 
TOTAL 1674650.9 9 186072.3 
SOURCE 
176 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEl) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEl 19851.9 1 19851.9 1 . 2 
EXPLAINED 63631.9 2 31815.9 2.0 
RESIDUAL 107925.6 7 15417.9 
TOTAL 171557.6 9 19061.9 
SOURCE 
177 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 56659.8 1 56659.8 1. 7 
EXPLAINED 60898.0 2 30449.0 0.9 
RESIDUAL 229932.3 7 32847.5 
TOTAL 290830.4 9 32314.8 
SOURCE 
178 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 0.01 1 0.01 0.003 
EXPLAINED 3.8 2 1.9 0.5 
RESIDUAL 24.5 7 3.5 
TOTAL 28.4 9 3.1 
SOURCE 
179 
EXPERIMENT 2 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 8.1 1 8.1 0.2 
EXPLAINED 8.5 2 4.2 0.8 
RESIDUAL 206.3 7 29.4 
TOTAL 214.9 9 23.8 
SOURCE 
180 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 17.4 2 8.7 0.4 
EXPLAINED 32.1 3 10.7 0.5 
RESIDUAL 243.3 12 20.2 
TOTAL 275.4 15 18.3 
SOURCE 
181 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUEN CY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 17.8 2 8.9 0.3 
EXPLAINED 19.8 3 6.6 0.2 
RESIDUAL 301.6 12 25 . 1 
TOTAL 321.4 15 21.4 
SOURCE 
182 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 289021.7 2 144510.8 3.9* 
EXPLAINED 452075.6 3 150691.8 4.1 
RESIDUAL 436115.3 12 36342.9 
TOTAL 888191.0 15 59212.7 
SOURCE 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 498079.4 2 249039.7 4.9* 
EXPLAINED 424535.4 3 141511.7 2.4 
RESIDUAL 606557.5 12 50546.7 
TOTAL 1131092.9 . 15 75406.1 
SOURCE 
184 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 619163.5 2 334581.7 2.6 
EXPLAINED 673137.9 3 224379.3 1.7 
RESIDUAL 1500071.5 12 125005.9 
TOTAL 2173209.4 15 144880.6 
SOURCE 
185 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 111698.6 2 55849.3 0.7 
EXPLAINED 168404.0 3 56134.3 0.7 
RESIDUAL 934447.8 12 77870.6 
TOTAL 1102851.9 15 73523.4 
SOURCE 
186 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEI 667.7 2 333.8 0.05 
EXPLAINED 993.1 3 331.2 0.05 
RESIDUAL 71651.9 12 5970.9 
TOTAL 72645.0 18 4843.0 
SOURCE 
187 
EXPERIMENT 3 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 4821.6 2 2410.8 2.1 
EXPLAINED 11996.2 3 3998.7 2.7 
RESIDUAL 11987.8 12 799.1 
TOTAL 20984.0 15 1165.7 
SOURCE 
188 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 82.5 3 27.4 3.4* 
EXPLAINED 82.5 4 20.6 2.6 
RESIDUAL 212.3 27 7.8 
TOTAL 294.8 . 31 9.5 
SOURCE 
189 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 24029.6 3 8009.8 1.3 
EXPLAINED 64100.4 4 16025.1 2.6 
RESIDUAL 162829.0 27 6030.7. 
TOTAL 226929.4 31 7320.3 
SOURCE 
190 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 138625.9 3 46208.6 5 . 7* 
EXPLAINED 244297.9 4 61074.4 7.6 
RESIDUAL 215834.5 27 7993.8 
TOTAL 460132.4 31 14842.9 
SOURCE 
191 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 252.5 3 84.1 3.8* 
EXPLAINED 266.5 4 66.6 3.0 
RESIDUAL 584.6 27 21.6 
TOTAL 851 . 2 31 27.4 
SOURCE 
192 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 1850287.5 3 616762.5 4.6* 
EXPLAINED 2153684.8 4 538421.2 4.1 
RESIDUAL 3617735.6 27 133990.2 
TOTAL 5771420.4 31 186174.8 
SOURCE 
193 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 997927.5 3 332642.5 3.3* 
EXPLAINED 1140078.9 4 285019.7 2.8 
RESIDUAL 2919808.9 27 100733.6 
TOTAL 3859887.8 31 124512.5 
SOURCE 
194 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEl) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEl 32830.5 3 10943.5 3.2* 
EXPLAINED 55318.3 4 13829.5 4.0 
RESIDUAL 91466.4 27 3387.6 
TOTAL 146784.8 31 4734.9 
195 
EXPERIMENT 5 
SUMMARY OF ANALYSIS OF COVARIANCE (RECIPROCALS) 
INTERCOPULATORY INTERVAL (ICI) 
SOURCE SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 0.001 3 0.0000 2.8 * 
EXPLAINED 0.001 4 0.0000 2. 1 
RESIDUAL 0.004 27 0.0000 
TOTAL 0.005 31 0 .0000 
SOURCE 
196 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 648.6 1 648.6 0 . 2 
EXPLAINED 3910.5 2 1955 . 2 0. 7 
RESIDUAL 30586.8 12 2548.9 
TOTAL 34497.3 14 2464 . 0 
SOURCE 
197 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 21273.8 1 21273.8 3. 3 
EXPLAINED 99692.1 2 49846.0 7. 9 
RESIDUAL 75521.6 12 6293.5 
TOTAL 175213.7 14 12515.2 
SOURCE 
198 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 720.0 1 720.0 2.0 
EXPLAINED 1403.2 2 701.6 1. 9 
RESIDUAL 4220.4 12 351.7 
TOTAL 5623.7 . 14 401 . 6 
SOURCE 
199 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 238713.0 1 238713.0 1.6 
EXPLAINED 282898.5 2 141449.2 0.9 
RESIDUAL 1767897.0 12 147324.7 
TOTAL 2050795.6 14 146485.4 
SOURCE 
200 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
** *************************************************************** 
IF 240.7 1 240.7 7 . 1* 
EXPLAINED 272.7 2 136.3 4 . 0 
RESIDUAL 402.9 12 33.5 
TOTAL 675.7 14 48.3 
SOURCE 
2:01 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 22.1 1 22.1 2.1 
EXPLAINED 59.2 2 29.6 2.8 
RESIDUAL 124.4 12 10.3 
TOTAL 183.7 14 13.1 
SOURCE 
202 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 406040.2 1 406040.2 2.5 
EXPLAINED 584667.6 2 292333.8 1.8 
RESIDUAL 1947698.0 12 162308.1 
TOTAL 2532365.7 14 180 88 3.2 
SOURCE 
203 
EXPERIMENT 7 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEl) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEl 16341.0 1 16341.0 6.9* 
EXPLAINED 22828.7 2 11414.3 4.8 
RESIDUAL 50911.6 14 2340.2 
TOTAL 50911.6 14 3636.5 
SOURCE 
204 
EXPERIME NT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 
EXPLAINED 
RESIDUAL 
TOTAL 
1372.7 
92012.6 
38071.1 
130083.7 
1 
2 
12 
14 
1372.7 
46006.3 
3172.5 
9291.6 
0.4 
14 . 5 
SOURCE 
205 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 3.2 1 3.2 0.04 
EXPLAINED 71974.3 2 35978.1 11.2 
RESIDUAL 38279.3 12 3189.9 
TOTAL 110253.6 14 7875.2 
SOURCE 
206 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 169053.1 1 169053.1 1.4 
EXPLAINED 1034143.3 2 517071 . 6 4.4 
RESIDUAL 1400861.5 12 116738.4 
TOTAL 2435004.9 14 173928.9 
SOURCE 
207 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
********** ******************************************************* 
ICI 4379.1 1 4379.1 2.1 
EXPLAINED 5369.0 2 2684.5 1.3 
RESIDUAL 24250.2 12 2020.8 
TOTAL 29619.3 14 2115.6 
SO.URCE 
208 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 144013.9 1 144013.9 1 . 3 
EXPLAINED 321182.5 2 160591.2 1.5 
RESIDUAL 1274221.0 12 106185.0 
TOTAL 1595403.5 14 113957.4 
SOURCE 
209 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 9.4 1 9.4 0.6 
EXPLAINED 9.4 2 4.7 0.3 
RESIDUAL 176.1 12 14.6 
TOTAL 185.6 14 13.2 
SOURCE 
210 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEI 581.1 1 581.1 0 . 1 
EXPLAINED 3024.4 2 1512.3 0.3 
RESIDUAL 60356.2 12 5029 . 6 
TOTAL 63380.9 14 4527.2 
SOURCE 
211 
EXPERIMENT 8 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 149.1 1 149.1 5.2* 
EXPLAINED 150.0 2 75.0 2.6 
RESIDUAL 342.3 12 28.5 
TOTAL 492.4 14 35.1 
SOURCE 
212 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 95521.7 1 95521.7 11.9* 
EXPLAINED 96285.0 2 48142.5 6.0 
RESIDUAL 88206.2 11 8018.7. 
TOTAL 184491.2 13 14191.6 
SOURCE 
213 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 3888.6 1 3888.6 5.1* 
EXPLAINED 5952.6 2 2796.3 3. 9 
RESIDUAL 8231.3 11 748.3 
TOTAL 14184.0 13 1091.0 
SOURCE 
214 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 480155.4 1 480155.4 9.8* 
EXPLAINED 1343664.1 2 671832.0 13.8 
RESIDUAL 535449.8 11 48677 . 2 
TOTAL 1879114.9 13 144547.2 
SOURCE 
215 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 288108.1 1 288108.1 8.6* 
EXPLAINED 1319102.2 2 659551.1 19.1 
RESIDUAL 368096.5 11 33463.3 
TOTAL 1687198.8 13 129784.5 
SOURCE 
216 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEI 3890.5 1 3890.5 0.5 
EXPLAINED 7874.0 2 3937.0 0 . 3 
RESIDUAL 115269.1 11 10479.0 
TOTAL 123143.1 13 9472.5 
SOURCE 
217 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 2667.1 1 2667.1 5.2* 
EXPLAINED 5280.7 2 2640.3 5.1 
RESIDUAL 5604.6 11 509.5 
TOTAL 10885.4 13 8 3 7. 3 
SOURCE 
218 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 5.1 1 5.1 1. 7 
EXPLAINED 34.8 2 17.4 5.9 
RESIDUAL 32.1 11 2.9 
TOTAL 66.9 13 5.1 
SOURCE 
219 
EXPERIMENT 9 
SUMMARY OF ANALYSIS OF CO VARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 5.5 1 5.5 1 . 8 
EXPLAINED 8.6 2 4 . 3 1 . 4 
RESIDUAL 32.7 11 2.9 
TOTAL 41.4 13 3.1 
SOURCE 
220 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT LATENCY (ML) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ML 25233.7 3 8411.2 1.8 
EXPLAINED 28649.3 4 7162.3 1.5 
RESIDUAL 100955.8 22 4588.9 
TOTAL 129605.1 26 4984 . 8 
SOURCE 
221 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION LATENCY (IL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IL 34366.3 3 11455.4 0 . 8 
EXPLAINED 44549.1 4 11137.3 0.8 
RESIDUAL 291735.4 22 13260.7 
TOTAL 336284.6 26 12934.0 
SOURCE 
222 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
MOUNT FREQUENCY (MF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
MF 22.1 3 7.3 1 . 8 
EXPLAINED 26.5 4 6.6 1 . 6 
RESIDUAL 88 . 0 22 4.0 
TOTAL 114.6 26 4 . 4 
SOURCE 
223 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTROMISSION FREQUENCY (IF) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
IF 25.6 3 8.5 0.6 
EXPLAINED 46.5 4 11.6 0.9 
RESIDUAL 272.8 22 12.4 
TOTAL 319.4 26 12 .2 
SOURCE 
224 
EXPERIMENT ll 
SUMMARY OF ANALYSIS OF COVARIANCE 
EJACULATION LATENCY (EL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
EL 767576.9 3 255858.9 2 . 5 
EXPLAINED 1934879.2 4 483719.8 4.7 
RESIDUAL 2232693.4 22 101486.0 
TOTAL 4167572.7 26 160291.2 
SOURCE 
225 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
ADJUSTED EJACULATION LATENCY (AEL) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
AEL 434779.4 3 144926.4 2.1 
EXPLAINED 921625.0 4 230406.2 3.3 
RESIDUAL 1502753.5 22 68306.9 
TOTAL 2424378.6 26 93245.3 
SOURCE 
226 
EXPERIMENT 11 
SUMMARY OF ANALYSIS OF COVARIANCE 
POSTEJACULATORY INTERVAL (PEl) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
PEl 24183.3 3 8061.1 2.7 
EXPLAINED 26066.5 4 6516.6 2 . 2 
RESIDUAL 63810.5 22 2900.4 
TOTAL 89877.1 26 3456.8 
SOURCE 
227 
EXPERIMENT ll 
SUMMARY OF ANALYSIS OF COVARIANCE 
INTERCOPULATORY INTERVAL (ICI) 
SUM OF SQUARES DF MEAN SQUARE F 
***************************************************************** 
ICI 5833.5 3 1944 . 5 1 . 7 
EXPLAINED 5898.2 4 1474 . 5 1.3 
RESIDUAL 23832.3 22 1083 . 2 
TOTAL 29730.6 26 1143.4 



